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Abstract
Cataracts, the commonest cause of blindness in the world, may be broadly divided 
into adult onset and childhood onset. Some childhood cataracts are present from 
birth (congenital cataracts). About one third of congenital cataracts occurring as 
isolated abnormalities, and not part of a syndrome, are inherited. Full clinical 
examination was performed on individuals from families with inherited cataracts. 
DNA was extracted from peripheral blood samples. Linkage analysis was 
performed in three large families.
Key individuals were examined from two of these families with autosomal 
dominant congenital cataract (ADCC). In one of the families, cataract was linked 
and linkage refined to a region encompassing the transcription factor gene, PITX3, 
known to be associated with cataracts and anterior segement mesenchymal 
dysgenesis (ASMD). Both families were found to have the same mutation in this 
gene, which segregated with disease and was absent in control individuals. The 
phenotype in these families, posterior polar cataract with or without ASMD, is
t
different from that previously reported for this mutation and shows both inter- and 
intra-familial variability.
Autosomal dominant (AD) zonular pulverulent cataract in a third large family was 
linked to the connexin 46 gene (CX46), known to be associated with cataracts. 
Sequence analysis identified a novel mutation in this gene which segregated with 
disease in the family and was absent in control individuals. Wild type and mutant 
constructs of CX46 were prepared and expressed in human HeLa cells. These
2
studies demonstrated that the mutation does not affect trafficking of the protein to 
the cell membrane.
Individuals from twenty-one further families with inherited cataract were 
examined clinically. Their DNA samples were added to the existing panel for 
candidate gene screening.
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1.0 Introduction
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1.1 Cataract as a Disease
Cataract, opacification of the crystalline lens of the eye, is the commonest cause 
of blindness in the world. The World Health Organisation estimates that 45 
million people in the world are blind, 19 million of them as a result of cataract.1 
Cataracts may be broadly divided into adult onset and childhood onset (either 
congenital or infantile). Childhood cataract is both phenotypically and 
genotypically heterogeneous. Congenital cataract is defined as cataract which is 
present from birth and is responsible for approximately one-tenth of worldwide 
childhood blindness.2 Childhood cataracts account for about 10-20% of childhood 
blindness in developing countries3 and about 4% of adult blindness in 
industrialised countries.4 According to the US collaborative perinatal project,5 
childhood cataract has a prevalence of 13.6 cases per 10,000 live births. The 
incidence of congenital cataract in the UK and Australia is between 2.2 and 2.49 
per 10000 live births.6’7
The visual outcome for congenital cataract depends on whether the cataract is 
total or not at birth, whether the cataract is progressive or stationary and, in the 
case of severe cataract, the age at surgery. Total congenital cataract requires early 
cataract surgery and visual rehabilitation. This contrasts with partial progressive 
cataract, for which surgery can often be delayed until later childhood with good
Q
visual outcome. Partial stationary cataract may not require surgery and has the 
best prognosis of all.
Childhood cataracts may be inherited or non-inherited. Intrauterine infections 
(rubella, varicella, toxoplasmosis), trauma and juvenile ocular inflammatory
15
disease are the commoner causes of non-inherited cataract.9 Inherited cataract may 
occur as an isolated abnormality, as part of a more complex ocular developmental 
abnormality or as part of a systemic syndrome. About one third of isolated 
congenital cataracts are inherited,10 the commonest mode of inheritance being
7* i nautosomal dominant. ’ Autosomal recessive (AR) and X-linked recessive modes 
of inheritance are also seen but are uncommon. The emphasis of this thesis is on 
investigating and adding to existing knowledge and understanding of isolated 
ADCC.
7.2 Normal Lens Biology
1.2.1 Embryology
1.2.1.1 Lens vesicle formation
In humans, eye development begins around day 22 of gestation, when the embryo 
is approximately 2mm in length.11 Two hollow diverticulae, optic vesicles, are 
formed from neural ectoderm of the prosencephalon. The lens placode is 
recognisable on day 27 as a localised thickening of the surface ectoderm anterior 
to the optic vesicles. The single-layered spheroidal optic vesicle undergoes a 
critical transformation by means of active invagination to become a goblet-shaped 
optic cup. The lens placode invaginates in turn via a combination of differential 
growth and buckling to form the lens vesicle. By day 29, invagination of the lens 
placode is almost complete. A small lens pit can be identified just before the 
surface ectoderm seals over. As the vesicle, surrounded by its basal lamina, 
detaches from the surface ectoderm, it sinks into the underlying rim of the optic 
cup. By the start of day 36, the lens vesicle separates from the surface ectoderm.
16
The lens epithelial cells enclose the lens cavity and are surrounded externally by a 
basal lamina which will form the future lens capsule. Following separation of the 
lens vesicle from the surface ectoderm, this layer regenerates to form the fixture 
corneal epithelium.
1.2.1.2 Primary lens fibres
In response to an inductive signal from developing neural retina, the posterior 
cells of the lens vesicle elongate to form the primary lens fibres and begin 
synthesis of a new group of intracytoplasmic proteins known as crystallins. The 
base of each elongating lens cell remains anchored to the basal lamina posteriorly 
and their apices grow towards the anterior lens epithelium, thereby obliterating the 
lens cavity. The anterior cells of the lens vesicle remain as a single layer of 
cuboidal epithelial cells. The lens vesicle becomes a solid ball of cells by the end 
of the fourth week and is known as the embryonic lens nucleus.
1.2.1.3 Secondary lens fibres
Subsequent lens fibres arise from anterior lens epithelial cells that migrate 
equatorially and undergo a single mitotic division following which fiirther 
division does not occur. They are known as secondary lens fibres. The main 
function of the lens epithelium is to produce lens fibres and synthesise lens 
proteins. The newly differentiated fibre cells are deposited in concentric lamellae, 
resembling an onion skin, in a strictly ordered manner and continue to be formed 
throughout life. Superficially located lens fibres are rich in ribosomes, polysomes, 
and rough endoplasmic reticulum. They actively synthesise lens crystallins,
17
amongst other proteins. Maturation of the lens fibres is associated with loss of 
nuclei and all intracellular organelles. This has important implications. Mature 
lens fibres are not capable of fulfilling their metabolic cellular requirements. It is 
for this reason that intercellular communication between immature but 
metabolically active lens epithelial cells and mature but metabolically inactive 
lens fibres is essential. The lens functions as a syncitium, which will be discussed 
in section 1.2.2.3.
The tips of the secondary fibres extend around the primary fibres and meet at the
10Y-shaped anterior and posterior lens sutures. Every subsequent generation of 
fibres throughout life is added superficial to the previous layer. Early in 
embryonic development, the lens is nearly spherical. However, as secondary 
fibres are added at the equator, the lens becomes more ellipsoid, a trend that 
continues throughout life. Basal lamina material is continually deposited by the 
lens epithelium on its external aspect and encases the lens in a membranous non- 
cellular envelope, the lens capsule. During embryonic and foetal development, the 
lens receives nourishment via an intricate vascular net, the tunica vasculosa lentis 
that completely encompasses the lens by approximately nine weeks.
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1.2.2 Anatomy, biochemistry and physiology
1.2.2.1 Structure and Function
The lens is made up of three parts:
1. an elastic capsule
2. an anterior lens epithelium
3. the lens fibres
The lens capsule serves as a diffusion barrier. It is freely permeable to low 
molecular weight compounds but restricts the movement of large colloidal 
particles. The function of the lens epithelium is mainly twofold. The cells located 
at the equator are actively dividing, differentiating into lens fibres and 
synthesising proteins, including crystallins. The remaining, more centrally placed 
cells are involved in the transport of substances from the aqueous humour to the 
lens interior, and in the secretion of capsular material. As a result of the 
continuous production of lens fibres from the embryonic stage and the progressive 
internalising of the fibres, the earliest fibre mass in the centre of the lens is 
referred to as the embryonic nucleus. This is surrounded by the foetal nucleus 
with its Y-shaped sutures. Those fibres formed after birth constitute the earliest 
part of the fibre mass known as the adult nucleus. The area surrounding the adult 
nucleus, containing the recently formed nucleated fibres is called the lens cortex. 
The centre points on the anterior and posterior surfaces of the lens are known as 
the anterior and posterior poles. A schematic diagram of the lens showing all these 
zones is shown in Figure 1.
19
Figure 1 Schematic diagram of a human lens in sagittal section
Lens capsule
Anterior pole
Cortex
Foetal nucleus
Posterior pole
Embryonic
nucleus
Adult nucleus
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Lens fibres are hexagonal in cross section and are tightly packed with very little 
intercellular space. They are held together by the interlocking of their adjacent 
plasma membranes. The membranes contain numerous gap junctions. The close 
relationship that exists between the lens epithelial cells and the lens fibres, as seen 
by the interdigitation of the plasma membranes and the existence of numerous gap 
junctions, makes the lens a syncitium. From a physiological point of view, the
lens acts as a single cell. Its extensive intercellular gap junction communication
1 ^system maintains tissue homeostasis and hence transparency.
1.2.2.2 Lens size and shape
At birth, the crystalline lens is a transparent biconvex structure with an equatorial 
diameter of 6.5 mm and an anterior-posterior depth of 3.5 mm between its poles. 
The continual addition of lens fibres increases the equatorial diameter to 10 mm 
and the anterior-posterior depth to 4 mm by adulthood. The lens continues to 
gradually enlarge throughout life.
1.2.2.3 Lens homeostasis
During the fourth and fifth months of gestation, the tunica vasculosa lentis 
gradually atrophies. Following complete regression of the vascular system, the 
lens becomes an avascular organ with no lymphatic drainage. The lens fibres are 
now dependent on anterior epithelial cells to maintain homeostasis. These cells 
remove waste products and exchange them with nutrients from the aqueous 
humour through the semi-permeable capsule membrane.
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The lens behaves as a syncitium in which potassium ions (K+) are transported into 
the lens and sodium ions (Na+) are transported out via Na+/K+ ATPase present in 
the lens epithelium. The lens also contains specific glucose transporters and 
transporter molecules for ascorbate, which ensure adequate metabolism and 
minimise free radical damage. Glucose is derived from the aqueous, as are amino 
acids which are actively transported across the epithelium.
1.2.2.4 Lens cell membranes
Gap junction communication takes place between the aqueous humour and the 
anterior lens epithelial cells and between lens fibre cells. At the junction between 
the epithelium and the fibre cell, the main transport mechanism is rapid 
endocytosis via coated vesicles. Major intrinsic protein (MIP) is the principal 
protein constituent (50%) of fibre cell membranes, but it is absent from epithelial 
cells. MIP forms water channels. Membrane lipids are only produced by 
peripheral lens cells. There is no turnover of lipid in the membranes of mature 
fibre cells.
1.2.2.5 Lens metabolism
The lens has most of the biochemical pathways found in other tissues but all 
processes are not present in all cells because of the requirements for both 
transparency and a high refractive index. A high content of coloured molecules 
such as cytochromes and flavoproteins would absorb too much light, and if all 
cells contained a full complement of mitochondria and other organelles such as
22
the cell nucleus, too much light would be scattered. For similar reasons the lens is 
avascular.
The lack of organelles in mature lens fibres has two biochemical consequences. 
Firstly, the majority of the lens must obtain its energy from glycolysis, not from 
oxidative phosphorylation. Secondly, there is no synthesis of protein in the centre 
of the lens. Glucose from the aqueous humour is the main source of energy for 
lens metabolism. Glucose enters lens epithelial cells via insulin-dependent glucose 
transporters located in the plasma membrane. Approximately 90% of lenticular 
glucose is metabolised via the glycolytic pathway. As the lens fibre cells have no 
mitochondria, only epithelial cells are able to use oxidative phosphorylation for 
further ATP production. Under physiological conditions most glucose is 
metabolised via glycolysis to lactate, with the remaining 10% entering the pentose 
phosphate pathway for the synthesis of pentoses and NADPH. Sorbitol has been 
shown to accumulate in diabetic rat lenses, and this reaction was thought to be 
secondary to the activity of aldose reductase. In fact, although the enzyme exists 
in the lens, recent studies suggest that glucose may be an incidental substrate of 
aldose reductase and that sorbitol accumulation does not result in 
cataractogenesis.14 Cataract formation in diabetes is primarily caused by 
glycosylation of lens proteins, with the subsequent disruption of the Na+/K+ 
ATPase pump, and not by sorbitol accumulation.
Glutathione is found in high concentrations in the lens.15 Mostly (93%) it is found 
in its reduced form (GSH), and is maintained thus by the NADPH produced by 
the hexosemonophosphate shunt. A reduction of lens GSH is a consistent finding
23
in age-related and all tested experimental cataracts. Glutathione peroxidase is 
involved in the detoxification of hydrogen peroxide, some of which is formed 
from O2’ radicals.
1.2.2.6 Function of the lens
The purpose of the lens is to refract light rays onto the retina. The dioptric power 
of the entire eye is about 58 dioptres, with the cornea responsible for most of this 
refractive ability. The lens contributes only about 15 dioptres to the total power. 
The importance of the lens is that it can change its dioptric power, allowing 
distant and near objects to be focused onto the retina. The high refractive index of 
the lens is due to the crystallins. The transparency of the lens is due to the shape, 
arrangement, internal structure, and biochemistry of the lens cells and lens fibres.
1.2.2.7 Lens transparency
The transparency of the lens is largely the result of the structured packaging of 
macromolecular components within the lens fibres and the small differences in 
refractive index between light scattering components. The regular arrangement of 
lens fibres and the absence of tissues such as blood vessels and nerves also 
minimise light scatter. Lens transparency is a crucial trade-off between the 
concentration of the macromolecules and their hydration. Disruption of normal 
levels of hydration can lead to opacity. The single-celled epithelium of the lens 
and its capsule do not scatter or reflect light, essentially because the combined 
refractive index is the same as that of the aqueous humour.
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Light transmission by the lens is reduced when the ordered packing of the lens 
crystallins is disturbed. This can be induced in many ways, such as increased 
water accumulation within the lens, formation of high molecular weight lens 
protein aggregates, and vacuole formation within the lens fibres with age. Since 
the lens is designed for the transmission of light, it responds to any insult that 
disturbs normal development or metabolism, by opacification, even if the insult is 
only temporary.
1.3 Cataract phenotypes
The morphology of congenital cataract reflects a combination of the timing and 
nature of the cause, the anatomy of the lens, its pre- and post-natal development, 
and changes that take place with time.16 The morphology of congenital cataract is 
largely determined by the anatomy of the lens and the timing of the insult in 
embryogenesis. Morphology may variably affect prognosis, give a clue to the age 
of onset and, in an isolated case, sometimes suggest heritability. Certain 
phenotypes (lamellar, pulverulent, polymorphic, coralliform and cortical) seem to 
have good visual prognosis.8
Many classification systems have been proposed to categorise human inherited 
cataract morphology.9 This research focuses on isolated ADCC. Ten distinct 
clinical entities have so far been described for this subset of inherited cataracts in
17*18separate studies. ’ These phenotypes together represent a clinical classification 
system for this particular disorder. I have used this classification system which 
incorporates both the position of the opacity within the lens (Figure 1) and its
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appearance on slit-lamp examination. The ten separate phenotypes are described 
in this section, along with sutural cataract which, in AD disease, is only ever 
present in conjunction with at least one of the other phenotypes.
1.3.1 Anterior polar cataract (APC)
Anterior polar cataracts are situated at the anterior pole of the lens. They are 
usually symmetrical and discrete lesions. Anterior polar cataracts vary from single 
dot-like opacities to larger pyramidal-shaped opacities.18’19
1.3.2 Posterior polar cataract (PPC)
Posterior polar cataracts are located at the posterior pole of the lens. They are 
commonly symmetrical. PPC may be divided into stationary20’21 and progressive 
types.22’23 The progressive subtype spreads from the posterior pole over time. It is 
associated with a higher incidence and an earlier age of surgery.23’24 In PPC, 
opacification is close to the optically crucial, nodal point of the eye. Therefore, 
vision is commonly reduced.25
1.3.3 Nuclear cataract
Early onset nuclear cataracts are located in the embryonic and foetal nucleus of 
the lens. They vary widely in appearance and the need for surgery depends on the 
type of nuclear cataract. Confluent nuclear opacification often requires early 
surgery. On the other hand, blue dot nuclear cataract may not require surgery. 
Nuclear cataracts are usually static. Attempts to differentiate between embryonic
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and foetal nuclear cataracts were made in the past but are extremely difficult to 
make clinically. It is much easier to define these cataracts as nuclear and then 
subclassify them according to slit lamp appearance.
1.3.4 Lamellar
During normal lens growth, lamellae are formed from the concentric deposition of 
newly differentiated secondary lens fibres around the embryonic and foetal 
nucleus. Lamellar cataracts involve one or more lamellae or layers of the lens, as a
a . ') / :
shell of opacity, sandwiched between clear nucleus and cortex. ’ Lamellar 
cataract, sometimes referred to as zonular cataract, represents several generations 
of secondary lens fibres, which have become opacified in response to an insult 
when these fibres were at their most metabolically active. The opacification of 
discrete lamellae and the normal production of later lamellae suggest that the 
disruption to lens development is a transient event in this type of cataract. The 
majority of families develop lamellar cataract before birth. The density of the 
cataract varies significantly between individuals. The opacity may be so dense as 
to render the entire central region of the lens completely opaque, or so translucent 
that vision is hardly affected at all.
Typically, lamellar cataracts are bilateral but slightly asymmetrical, sometimes 
with different degrees of opacification in different meridians. They are composed 
of minute white dots in one or more layers of the lens, not involving the 
embryonic nucleus. They are usually sharply demarcated from a clear cortex 
outside them. They are often incomplete, and they may have projections from 
their outer edges known as riders. The visual prognosis, especially in partial
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27cataract, is probably better than in many other morphological types. Many cases 
can be managed conservatively and surgery in infancy is rarely necessary. 
However, there is often a marked intrafamilial variability28 and some lamellar 
cataracts have a poor visual outcome. This occurs if the opacity starts earlier 
during lens development, if the cataracts are denser and if they involve the centre 
of the lens. In such cases, profound amblyopia is common.
1.3.5 Pulverulent
Pulverulent cataracts have a pulverised (powdery) appearance to the opacification. 
Pulverulent cataracts have been reported in both AD29 and AR30 disease. 
Pulverulent opacities may be located throughout the lens or in a particular region.
^  i  l i
Nuclear pulverulent cataracts ' are confined to the nuclear region of the lens
and so are also a subtype of nuclear cataracts. “Zonular pulverulent cataract” is a
term which has been used to describe pulverulent cataracts which involve the
nucleus minimally but markedly affect lamellar regions beyond it.34'39 Pedigrees
affected by pulverulent cataract may show a wide intrafamilial variation in the 
1 8phenotype.
1.3.6 Coralliform
This is a rare form of congenital cataract. It is characterised by finger-like
18projections which resemble sea coral extending from the nucleus into the cortex. 
The visual impact is variable but cataract extraction is usually required in the early 
years of life. Coralliform cataract may well overlap with a similar rare phenotype, 
aculeiform or “needle-shaped” cataract.40
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1.3.7 Cerulean
Cerulean cataract is a distinctive type of cataract, both in terms of appearance and 
prognosis. It has not been observed in a neonate so may be a form of infantile 
rather than congenital cataract. It has been reported in childhood and progresses 
throughout early life. Discrete pinhead shaped blue and white opacities are 
distributed throughout the lens, becoming more numerous in the cortex where
1 ftthey may form large cuneiform (wedge-like) shapes in the mid-periphery.
Within a pedigree, this phenotype is consistent in its distribution but variable in its 
severity. Visual acuity is usually well preserved. Often surgery is not required 
until adulthood and it is usually associated with a good outcome.41
1.3.8 Cortical
This form of inherited cataract is rare. Opacification affects a sector of the lens in
1 ftthe outer cortex adjacent to the capsule. This represents a late insult since there 
is opacification in the more newly formed secondary lens fibres, which lie in the 
equatorial region of this zone. The other regions of the lens, including the visual 
axis, are clear. Therefore, an affected individual’s visual acuities are not reduced 
and the prognosis is excellent.
1.3.9 Polymorphic
Some cataract phenotypes show considerable variation in morphology even within 
the same family. The polymorphic cataract phenotype was first described in three
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families with wide variations in grape-like lens opacities that spared the nucleus.42 
The distribution of the opacities varied from the superficial to the deep layers of 
the cortex. The term polymorphic has since been used to characterise the cataract 
in another unrelated family with a similar distribution of opacities in association
17with asymmetric polar opacification.
1.3.10 Total
AD total congenital cataract has recently been reported in an Australian family.43 
Early cataract surgery is essential to limit amblyopia due to total lens 
opacification.
1.3.11 Sutural
This is not really a separate phenotype since it is rarely inherited without other 
forms of morphological change within the lens. In fact, there are currently no 
reports of isolated AD sutural cataract. The cataract consists of prominent 
opacification of the anterior and posterior sutures. Sutural opacities have been 
described in association with lamellar,44 pulverulent29 and nuclear45 cataracts. 
Isolated sutural opacities, although not reported in any AD pedigree, may be seen 
in female carriers of X-linked cataract, particularly Nance-Horan syndrome.46
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1.4 Genetic concepts
1.4.1 The human genome
The human genome has now been completely sequenced. A large number of 
disease loci have been mapped. In addition, genetic markers throughout the 
genome are available to help in mapping diseases to chromosomal loci. A genetic 
marker is any polymorphic Mendelian character that can be used to follow a 
chromosomal segment through a pedigree.47 Microsatellite markers are di-, tri-, 
and tetra-nucleotide repeats which are distributed throughout the genome. There 
are potentially more than 105 microsatellite loci. Each has many alleles and they 
are highly informative. By using informative markers in large families with 
ADCC, linkage can be established and the chromosomal locus of the causative 
gene identified.
1.4.2 Linkage
The principles of linkage are fundamental to understanding the molecular genetics 
of any inherited disease, particularly ADCC. The following explanation should 
aid this understanding.
If one flips a coin, just by chance alone, there is a 50% chance that it will land 
heads and a 50% chance it will land tails. If one flips a coin ten times, just by 
chance alone, it will land heads five times and it will land tails five times. If it 
lands heads more than five times or less than five times, the further away from 
five times this happens, the less likely that this has happened by chance alone, and
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the more likely that something has caused this outcome number to be skewed one 
way or the other.
Similarly, if  one investigates a family in which a disease is inherited and looks at 
a marker at a specific place on a chromosome, there is a 50% chance that the 
marker and the disease will segregate together by chance alone, i.e. that no 
crossover will intervene. A crossover, that is to say, exchange of genetic material 
between a pair of chromosomes, separates two points on a chromosome that are 
far apart. If the marker and the disease segregate together in more than 50% of the 
informative meioses, for example in more than five out of ten children in a large 
family, then the more times they segregate together, the more likely that the 
marker and the disease phenotype are located close together on the chromosome. 
This observation is compatible with linkage. The closer two points are on a 
chromosome physically, the more likely they will be inherited together. The more 
the number of informative meioses in which the two points segregate together, the 
closer together the two points are. If one looks at enough informative meioses, i.e. 
a large enough family, soon a point will come where the chances of the two points 
segregating together by chance alone is so small that it is not happening by 
chance. Rather, the two points are physically extremely close. This observation is 
compatible with linkage.
The probability of flipping a coin and getting heads ten times in a row is worked 
out as: xA x xA x  V2 x V2 x XA x XA x V2 x XA x XA x XA = 1/1024. This is the odds ratio. 
Only once in 1024 times will one flip a coin and get ten heads in a row by chance 
alone. 1023 times one will get at least one tails. Now, the LOD score gives the
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logarithm of the odds ratio. This is a quantitative measurement of linkage. For 
example, if the odds ratio was one thousand, there would be a one in a thousand 
probability of a particular event occurring by chance alone. The LOD score in this 
case would be three, the logarithm of one thousand. A LOD score of three or more 
indicates that the odds of linkage being present are one thousand to one in favour 
of linkage. 999 times out of one thousand this result is happening because there is 
linkage. Only once in one thousand times is it happening by chance alone.
Now, a marker can be relatively close to a disease locus. In this case, the 
percentage of meioses in which the two points are linked is higher than by chance 
alone, but they may not segregate together as linked loci in all the meioses. The 
closeness of the marker to the disease is reflected by the theta value (0), the 
recombination frequency. For instance, if a significant maximum LOD score is 
obtained at a theta value of 0.01, this is saying that IcentiMorgan (cM) away from 
the marker, the disease gene is likely to be found. Two loci that show 1% 
recombination between them are defined as being lcM apart on a genetic map.
1.43 Principal ways of finding genes in families with ADCC
There are two main methods of finding these genes. If the family with ADCC is 
large enough to provide a sufficient number of informative meioses, linkage can 
be established. Linkage is established when the disease locus and the genetic 
marker used are sufficiently close together on the chromosome. Using other 
nearby genetic markers, the points on the chromosome where the upper and lower 
(flanking) crossovers are found can be established. This leads to a region of 
linkage being refined. Within this region, candidate genes can be sequenced
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looking for a mutation which segregates with cataract in the family. Additional 
mutations in other families confirm the involvement of that gene in 
cataractogenesis.
If the family is too small for linkage to be statistically possible and if the 
phenotype is highly suggestive of a known cataract gene, then that gene can be 
sequenced directly in an affected individual to look for a mutation. A true 
cataract-causing mutation should segregate with cataract in the family and be 
absent in a large control panel of individuals without cataract.
1.4.4 Cataract panel
New candidate genes can be screened across a panel of individuals from unrelated 
families affected with inherited congenital cataract. From each family, an affected 
individual is screened for mutations in a gene. If a mutation is found and is not 
present in an unaffected individual from the same family, the rest of the 
individuals in that family are screened. If the mutation segregates with cataract in 
the family, its presence is tested for in a large control panel of individuals without 
cataract to see if it is a true candidate gene. More than one mutation in different 
individuals from the panel implicates the gene in cataract.
1.4.5 Importance of accurate phenotyping
It is clear from the above section on linkage that inaccurate phenotyping, in 
particular describing an individual as affected when in actual fact they are 
unaffected and vice versa, can have serious effects on establishing linkage in a
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family. In congenital cataract, it is extremely important to confirm a history of 
cataract from birth. Phenocopies, such as in age related cataract, if not recognised 
as such, could result in correct linkage not being found.
1.5 Cataract genetics
Currently fifteen genes are known to cause isolated inherited cataracts. Fourteen 
cause AD cataract and one causes AR cataract.48 There are at least nine additional 
loci associated with cataract at which the causative genes have not yet been 
identified. Six of these are associated with AD cataract and three are associated 
with AR cataract.48 In this section, the genes and loci reported to be associated 
with ADCC will be described.
1.5.1 Genes associated with ADCC
Mutations in genes encoding four major classes of proteins have been causally 
linked with ADCC. These classes of proteins are:
1. Crystallins, the predominant structural proteins in lens fibres
2. Lens fibre membrane proteins
3. Transcription factors important in lens development
4. Lens fibre cytoskeletal proteins
1.5.1.1 Crystallins
Crystallins are ubiquitous proteins found in many tissues where they serve 
multiple functions. Crystallins make up 90% of the water-soluble proteins of the 
lens. Three types of crystallins have been identified in mammals: a, P and y, 
mainly differentiated on the basis of molecular weight, a-crystallins are the largest
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lenticular proteins and consist of 30-40 subunits, which are of two types, aA and 
cxB. These subunits undergo extensive enzymatic and non-enzymatic post- 
translational modification. As in all crystallins, the basic structure is a (3-sheet. In 
addition to their role as structural lens proteins, a-crystallins have a role as 
molecular chaperones guiding the correct packing of other crystallins and folding 
of the cytoskeleton.49 This phenomenon of multiple uses of a protein encoded by a 
single gene, termed “gene sharing”, seems likely to be widespread in the lens, 
cornea and other ocular tissues.50 P-crystallins are aggregates of polypeptides (23- 
35kDa) whereas y-crystallins are monomers of 20kDa. There are acidic (A) and 
basic (B) p-crystallins.
During lens embryogenesis, an inductive signal from developing neural retina 
causes the posterior cells of the lens vesicle to elongate. They form the primary 
lens fibres and begin synthesising a new group of intracytoplasmic proteins, 
crystallins. Secondary lens fibres arise from anterior lens epithelial cells that 
migrate equatorially and undergo a single mitotic division following which further 
division does not occur. Superficially located secondary lens fibres are rich in 
ribosomes, polysomes, and rough endoplasmic reticulum. They also synthesise 
lens crystallins. As secondary lens fibres mature, they lose their nuclei and all 
intracellular organelles. Therefore, crystallin synthesis ceases, p- and y- crystallins 
fold into four “Greek key motifs”51 that facilitate tight packing of the molecules, 
thereby minimising light scatter. In contrast, a-crystallin, the most abundant lens 
crystallin, assumes a globular conformation that may be related to its role as a 
molecular chaperone.52 The purpose of the lens is to refract light rays onto the 
retina. The high refractive index of the lens is due to the crystallins. The
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structured packaging of crystallins in lens fibres and their solubility state are 
critical factors in maintaining lens transparency. Unsurprisingly, mutations in 
crystallins have been reported to cause ADCC.
1.5.1.1.1 a-crystallins
a-crystallins are of two types, aA and aB. A missense mutation, R116C, in the 
gene encoding aA crystallin (CRYAA) has been reported to cause nuclear 
cataracts.53 In addition to cataract, five out of ten affected individuals in the family 
also had microcomea. This suggests that a-crystallins may play a role in the 
normal development of the anterior segment. However, this may be non-specific 
since any disruption to the normal early development of the lens may lead to 
consequences such as microcomea or microphthalmos.54 Two mutations in 
CRYAB, the gene encoding aB crystallin, have been reported in association with
OfiADCC. A deletion mutation, 450delA, has been reported to segregate with PPC. 
The mutation resulted in a frameshift in codon 150 and produced an aberrant 
protein consisting of 184 residues. A missense mutation, R120G, has been 
reported in a family with cataract (no phenotype described in the paper) and 
desmin-related myopathy.55 Presumably, the myopathy was caused by failure of 
the normal aB crystallin chaperone activity. In an elegant study, a mammalian 
two-hybrid system was used to investigate the effects of the R116C CRYAA and 
R120G CRYAB mutants on interactions between these proteins and other major 
lens constituents in vitro. The findings support the hypothesis that the functional 
effects of the mutations are to reduce protein solubility, increasing the likelihood 
of precipitation, seen clinically as cataract.56
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1.5,1.1.2 p- and y-crystallins
The p- and y-crystallin polypeptides are recognised as members of a related p/y- 
crystallin superfamily. The p-crystallin family consists of four acidic (A) and 
three basic (B) forms, y-crystallins are also subdivided into a number of types. Of 
the y-crystallins, only yC and yD, encoded by CRYGC and CRYGD respectively, 
are highly expressed in the human lens.
A number of mutations in p-crystallin genes associated with AD cataract have 
been reported. A nonsense mutation, Q155X, in the CRYBB2 gene has been 
associated with cerulean cataract,57 cerulean and sutural cataract45 and nuclear
fO
pulverulent cataract in three unrelated families. The variable phenotype with an 
identical mutation suggests that other modifier genes or, perhaps less likely, 
environmental factors may influence the phenotype. Two different splice site 
mutations in CRYBA1 have been reported in unrelated families with pulverulent 
cataract29,44 A CRYBB1 nonsense mutation, G220X, has been implicated in a 
family with pulverulent cataract.59
A number of mutations in y-crystallin genes have been reported in association 
with ADCC. A missense mutation, T5P, in CRYGC has been reported in 
association with pulverulent cataract.60 A five base pair (bp) duplication mutation 
in CRYGC has been reported in a family with zonular pulverulent cataract.61 A 
missense mutation, R168W, in CRYGC has been associated with lamellar 
cataract.62 Several mutations in CRYGD have been reported in association with 
cerulean (P23T),63 aculeiform (R58H),60 nuclear (W156X)62 and lamellar
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(P23T)62 cataract. A spontaneous heterozygous missense mutation in CRYGD, 
R36S, has also been detected in a boy with congenital prismatic cataracts.64 
Functional studies have shown that both the R58H and the R36S mutations reduce 
the solubility of CRYGD proteins rendering them prone to crystallisation.64’65 
This provides an explanation as to how these mutations could result in cataract. 
Further work is needed to investigate whether this is the mechanism by which 
other yD crystallin mutations cause cataract.
1.5.1.2 Lens fibre membrane proteins
Connexin gap junctions are found in the cell membranes of anterior lens epithelial 
cells and lens fibre cells. Proteins known as major intrinsic protein (MIP) of the 
lens are the principal protein constituent (50%) of fibre cell membranes, but are 
absent from epithelial cells.66 MIP forms water channels or aquaporins. Lens 
epithelial cell membranes also contain Na+/K+ ATPase pumps and transporter 
proteins for glucose and ascorbate. All these membrane proteins are vital for 
maintaining lens homeostasis. Mutations in the genes encoding them could 
theoretically cause cataract. Indeed, mutations in both connexins and in aquaporin 
0, the lens aquaporin, have been associated with ADCC.
1.5.1.2.1 Connexins
Connexins are gap junction proteins.67 Gap junctions are relatively non-specific 
intercellular membrane channels. Molecular movement through them occurs by 
passive diffusion. Gap junction channels allow selectivity of passage based 
principally on molecular size, allowing the movement of molecules smaller than 
1000 Daltons, such as cyclic AMP, but preventing the movement of proteins or
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nucleic acids. This allows small informational molecules to be directly transmitted 
between cells. Consequently, this type of communication is an important 
mechanism for regulating events between cells in embryogenesis.
Apart from a few terminally differentiated cells, such as skeletal muscle, red 
blood cells, and circulating lymphocytes, most cells in normal tissues generally 
possess and communicate via gap junctions. These junctions exist in almost all 
organisms, both vertebrates and invertebrates. In humans, at least twenty connexin 
genes have been associated with several different diseases including genetic 
deafness, skin disease, peripheral neuropathies, heart defects and cataracts.69
Connexins are a multigene family of proteins. Two alternative nomenclature 
systems, one based on the molecular mass of the connexin polypeptide and the 
other based on evolutionary considerations are currently in use.70 For simplicity 
sake, the former classification system is used in this thesis. The lens expresses 
three distinct connexins, connexin 43 (a 43kDalton protein), connexin 46 (a 
46kDalton protein) and connexin 50 (a 50kDalton protein), all of which appear to 
have different functions in maintaining lens homeostasis.69 Connexin 43 (Cx43) is 
expressed mainly in lens epithelial cells, while connexin 46 (Cx46) and connexin 
50 (Cx50) are expressed in lens fibre cells.71'73 Mutations in Cx46 and Cx50 have 
been reported in association with ADCC.
Gap junctions exhibit a hierarchy of assembly.67 The principal structural 
component is the membrane protein connexin. Six connexins combine to form a 
connexon. An individual connexon from one cell docks or associates with a
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corresponding connexon on a neighbouring cell to form a gap junction channel, 
and multiple channels, in turn, cluster or aggregate in the plane of the membrane 
to form gap junction plaques. The properties of the gap junction channels are 
defined by the connexins. The different connexin isoforms may associate with 
each other in many different combinations. This could significantly influence 
properties such as permeability and gating of the gap junction channels that are 
formed. Connexons may be homomeric (composed of six identical connexin 
subunits) or heteromeric (composed of more than one species of connexins). 
Connexons associate end to end to form a double membrane gap junction channel. 
The channel may be homotypic (if connexons are identical) or heterotypic (if the 
two connexons are different). In lens fibres, Cx46 and Cx50 pair up with each
71other in this way.
Seven and four different cataract-causing mutations in CY4d31’33;35;36;38 and CX50 
34;37;39;74 reSpectiVely have been reported to date. All but one of the eleven 
mutations have been associated with pulverulent congenital cataracts, either 
predominantly in the nuclear or the lamellar regions of the lens. All connexins 
have four transmembrane domains and two extracellular loops with cytoplasmic N 
and C termini. The previously reported mutations associated with congenital 
cataracts are summarised in table 1.
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Table 1 Previously reported mutations in connexin genes associated with cataract
Gene Mutation Location Reference
CX46 1137insC C-terminal cytoplasmic tail Mackay et al, 1999
N63S First extracellular loop Mackay et al, 1999
P187L Second extracellular loop Rees et al, 2000
F32L First transmembrane domain Jiang et al, 2003
P59L First extracellular loop Bennett et al, 2004
R76H First extracellular loop or second 
transmembrane domain
Burdon et al, 2004
N188T Second extracellular loop Li et al, 2004
CX50 P88S Second transmembrane domain Shiels et al, 1998
E48K First extracellular loop Berry etal, 1999
I247M C-terminal cytoplasmic tail Polyakov et al, 2001
R23T N-terminal cytoplasmic tail Willoughby et al, 2003
Mutations in connexins can affect gap junction function in several ways. The 
mutation may prevent normal intracellular trafficking of the connexin protein to 
the cell membrane. Alternatively, the mutant protein may traffic to the cell 
membrane but its function may be affected. Functional gap junction channels may 
not be formed. The properties of the gap junction channel may be affected so that 
the molecular selectivity of the channel or its voltage gating are changed.
Two main approaches have been used to demonstrate localisation of connexin 
proteins. Firstly, antibodies to the specific connexin have been used to localise it 
by immunohistochemistry.75'77 Secondly, fusion proteins composed of connexin 
and a fluorescent tag have been expressed in connexin-deficient cell lines.77*79 A 
major advantage of the latter approach is that it is easy to identify which cells 
have been transfected and, since they do not need to be fixed, function can be 
assayed in the live fluorescently tagged cells.
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Functional work has been performed on the N63S and 1137insC CX46 mutants.80 
Voltage-clamp studies were used to assay function of the expressed connexins. 
Neither of the two mutant connexins was able to form intercellular channels when 
expressed in paired Xenopus oocytes. The mutants were also impaired in their 
ability to form hemi gap junctional channels. When each of the mutants was 
coexpressed with wild-type connexins, both mutations acted like “loss of 
function” rather than “dominant negative” mutations, because they did not affect 
the gap junctional conductance induced by either wild type Cx46 or wild type 
Cx50. Using the same expression system, the functional effect of the P88S
O 1
mutation in CX50 was investigated. The mutant connexin again failed to form 
functional gap junctional channels when paired homotypically. However, this 
time the mutant functioned in a dominant negative manner when co-expressed 
with wild-type Cx50. Only one of these mutant subunits is necessary per gap 
junctional channel to abolish channel function.
The Xenopus oocyte system is rapid and sensitive but requires the blocking of 
endogenous connexin expression using antisense technology.82 Mammalian cells 
selected for transfection studies that do not express functional levels of connexin 
protein ’ offer a more native system to study the behaviour of mammalian 
connexins. Initial functional work on CX46 mutants was performed in Xenopus 
oocytes. Since that time the effects of mutations on connexin function have been 
investigated by microinjecting tracer dyes into transfected cells and monitoring 
for dye transfer to adjacent transfected cells through connexin gap junctions.77' 
79;83;85-89 ^  v a r j e t y  0f  ce\\ types have been transfected with connexins for dye
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injection studies including human HeLa cells,77'79,83’88"90 rat PC 12 cells,88 monkey 
COS-7 cells,88 Neuro2A cells,89 Xenopus oocytes78 and a keratinocyte cell line.85 
Localisation of the connexin proteins has been established using fluorescent 
protein tagging of the connexins or immunohistochemistry utilising connexin 
antibodies.75'77;83;85'90
1.5.1.2.2 Aquaporin 0 or major intrinsic protein (MIP)
Aquaporin 0 or MIP is a member of the aquaporins, a ubiquitous family of 
membrane water transport proteins that allow rapid movements of water across 
cell membranes.91 Aquaporin 0 is expressed in lens fibres. Two different 
mutations in it have been associated with ADCC.92 The missense mutation T138R
1 n
has been reported in association with a polymorphic cataract phenotype. The 
cataract consisted of bilateral discrete progressive punctuate lens opacities limited 
to mid and peripheral lamellae with additional asymmetric polar opacification.
The missense mutation E134G resulted in non-progressive lamellar cataract. In 
vitro functional analyses concluded that neither mutant protein is trafficked to the 
cell membrane possibly because of protein misfolding during synthesis in the 
endoplasmic reticulum.66 Both mutants interfere with the targeting of the wild- 
type protein thus explaining the dominant-negative effect of the mutations.
1.5.1.3 Transcription factors
Transcription factors are proteins required by RNA polymerases for recognition of 
specific stimulatory sequences in eukaryotic genes. Transcription factors may 
activate or repress transcription. They play an important role in the embryological
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development of the lens. They control the critical interaction between the 
embryonic surface ectoderm and the budding optic vesicle, which is essential for 
normal lens induction.93 They are expressed in a sequential fashion before and 
after contact between the optic vesicle and the surface ectoderm. The lens and the 
anterior segment are linked developmentally with a commonality of origin in 
surface ectoderm. In addition, there is a necessity for the separation of the corneal 
and lens surfaces for anterior chamber formation and a requirement for signalling 
from the lens for anterior segment organization.94 It is therefore not surprising that 
mutations in several transcription factor genes including PITX3,95 PAX6,96 
FOXE3,91 EYAln  and MAF"'m  have been implicated in AD congenital cataract 
and anterior segment mesenchymal dysgenesis (ASMD). Most mutations are 
associated with ASMD and cataract in all affected individuals within the family 
although typically there is phenotypic variability. A single family with a mutation 
in MAF has been reported in which some affected members of the family had both 
ASMD and cataract, while others had isolated cataract.99’100 Another transcription 
factor gene, HSF4, has been reported to cause isolated cataract in all affected 
individuals within a large family. Prior to the work described in this thesis, 
cataract causing mutations in PITX3 had only been reported in two families.95 One 
was a large family with a 17bp duplication mutation causing cortical cataracts and 
ASMD in all of the affected individuals. The second was a small family with a 
missense mutation resulting in total cataract. Both affected individuals from the 
small family developed glaucoma at a young age. The glaucoma may have been 
inherited as a form of mild ASMD.
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1.5.1.4 Cytoskeletal proteins
The structural framework of lens fibres is determined by the interaction of the 
cytoskeleton and cytoplasmic crystallins. Lens cells possess microfilaments, 
microtubules, and intermediate filaments. Microfilaments form a cytoskeleton, 
facilitate changes in cell shape, strengthen cell-to-cell contacts and define plasma 
membrane compartments. The microtubule cytoskeleton directs intracellular 
transport processes as well as contributing to the distribution of organelles. The 
intermediate filaments aid lens cells in overcoming physical stresses including 
lens accommodation.
1.5.1.4.1 Beaded filament structural protein 2 (BFSP2)
Secondary lens fibre differentiation is accompanied by the replacement of 
standard cytoskeletal elements by two intermediate filament proteins, BFSP2 and 
filensin, which assemble into a novel structure known as the beaded filament. A 
deletion mutation, AE233, in the BFSP2 gene has been reported in association 
with AD congenital nuclear and sutural cataracts.101’102 It seems highly likely that 
mutations in filensin may lead to ADCC.
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1.5.2 Loci associated with ADCC
At least six distinct further loci have been associated with ADCC (See Table 1). 
At least two different genes cause the three cataract phenotypes on chromosome 
ip.43
Table 1 Further loci for ADCC
The causative genes within these loci have not yet been identified
Locus Cataract phenotype Reference
lpter-p36.1
lp36
lpter
2pl2
15q21-q22
17pl3
17q24
20pl2-ql2
Nuclear and sutural
PPC
Total
Nuclear
Nuclear and sutural
APC
Cerulean
PPC
Eiberg et al, 1995 
Ionides et al, 1997 
McKay et al, 2005 
Khaliq et al, 2002 
Vanita et al, 2001 
Berry et al, 1996 
Armitage et al, 1995 
Yamada et al, 2000
1.6 Genotype-Phenotype Correlation
As more genetic mutations causing ADCC have been identified, it has been 
possible to build up a picture of the relationship between genotype and phenotype. 
Although it is possible to classify ADCC on the basis of phenotype, it is not 
possible to correlate phenotype to genotype with certainty. For example, two loci 
on lp3621 and 20pl223 and mutations in one gene, CRYAB on 1 lq21,20 have been 
reported in association with PPC. A particular cataract phenotype, in this case 
PPC, may not be related to a unique genotype. PPC shows genetic heterogeneity. 
Similarly, a particular cataract genotype does not always have a unique cataract 
phenotype - phenotypic heterogeneity. For example, mutations in CRYGD have 
been reported in association with cerulean (P23T),63 aculeiform (R58H),60 nuclear 
(W156X)62 and lamellar (P23T)62 cataract. In the case of the P23T mutation,
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different phenotypes, cerulean or lamellar may arise from the same mutation. 
Environmental, or more likely other genetic modifiers, may play a role in 
determining the eventual phenotype in a particular family.
However, some patterns do emerge. For example, ten out of eleven mutations 
reported in connexin genes, CX46 and CX50, result in pulverulent cataract.31"39’74 
It is possible that the mutation which has been reported to cause nuclear cataract74 
actually causes nuclear pulverulent cataract. In terms of lens biology, the fact that 
connexin mutations all result in powdery opacification throughout lens fibres is 
consistent with the function of connexins, which form gap junctions between 
adjacent lens fibres. If the function of gap junctions is impaired pre- and post- 
natally, it follows that lens homeostasis and hence transparency will be affected. 
Another example is seen with CRYGD mutations. Although a number of 
phenotypes have been reported in association with CRYGD mutations, two similar 
rare cataract phenotypes have only ever been reported in association with 
mutations in CRYGD -  aculeiform due to an R58H mutation60 and prismatic due 
to an R36S mutation.64 In both cases, the crystal-like appearance of the cataract 
reflects the biological malfunction caused by the mutation. These mutations 
reduce the solubility of yD-crystallins resulting in crystal formation within the 
lens.64’65
1.7 Purpose of research on ADCC
Cataract is the commonest cause of blindness in the world.1 It is a major public 
health problem. The only treatment currently available is surgical cataract 
extraction, most often combined with intraocular lens implantation. The majority
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of cataracts are age related. The commonest type leading to surgery is the nuclear 
type. Research into nuclear cataracts has focused mainly on environmental factors. 
Age, female sex, and smoking seem to be the most important risk factors.
Although environmental risk factors for age related cataract are well- 
established,103 age related cataract also has a strong genetic component to its 
aetiology.
The study of twins has been described as the "perfect natural experiment" in 
which to determine the relative importance of genetic and environmental 
factors.104 To estimate the heritabilityof a feature, the concordance or correlation 
of the feature between identical (monozygotic) twins and non-identical (dizygotic) 
twins is measured, and the magnitude of the concordance or correlation in the two 
types of twins is compared. The amount of nuclear cataract in a large sample of 
adult female twins was determined in order to estimate the relative role of genes 
and environment in the causation of such cataracts.105 The results showed that 
48% of the variation in severity of nuclear cataracts was due to genetic factors. 
Age accounted for 38% and other environmental factors for 14% of the variance. 
So, there is an important genetic component to age related cataract. It is likely that 
several different genes are involved. Sequence variants that are not pathogenic 
individually may cause an increased likelihood of cataract if present in 
combination with others. Providing statistical evidence of these associations will 
form the basis of unravelling the genetic nature of age related cataract.
The identification of the genetic mutations underlying congenital cataract and 
subsequent functional studies will improve our understanding of normal lens
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development and the mechanisms of cataractogenesis. This information, although 
important, is unlikely to lead to any major clinical advance in the prevention of 
congenital cataract as the cataracts in this age group are present from birth. 
However, gaining an understanding of the molecular mechanisms underlying 
congenital cataract will give us more clues as to the genes that cause age related 
cataract. The genes responsible for congenital cataract provide candidate genes 
and a rich source of possible polymorphisms that may contribute to aetiology of 
age related cataract. Although surgery for adult cataracts is generally associated 
with good visual outcomes, supply is unable to meet demand on a worldwide 
scale.106 With an increasingly ageing population, this discrepancy will only 
worsen. Therefore, potential non-surgical treatments based on the understandings 
gained from work such as this, may be able to prevent visual disability from 
cataracts becoming significant enough to warrant surgery in many people’s 
lifetimes, so alleviating an enormous public health problem.107
1.7 Aims of this thesis
In context to the above, the specific objectives of this thesis are to undertake 
genetic mapping of a cataract locus in a large family from Honduras, to undertake 
functional characterisation of the gene mutation, to characterise the phenotype and 
undertake genotyping in two large English families with ADCC and to add further 
families to the existing inherited cataract panel.
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2.0 Methods
51
2.1 Patients
2.1.1 Ethical approval
Approval for these studies was obtained from The Moorfields Eye Hospital 
Research Ethics Committee (project numbers BHAS1011 and MOOA183) and 
from the Institutional Review Board of Self Regional Healthcare IRC,
Greenwood, USA.
2.1.2 Consent
All individuals taking part in the studies gave fully informed written consent.
2.1.3 Phenotyping
Both affected and unaffected individuals underwent full clinical examination. This 
included comprehensive ophthalmic examination, with careful slit lamp 
examination and anterior segment photography where appropriate. A standard 
pro-forma was used. Individuals were phenotyped using the classification system 
which was outlined in the introduction. Pedigrees were constructed using Cyrillic 
version 2.1.3 software (FamilyGenetix Ltd., Oxford, UK).
2.1.4 Blood sample collection and storage
Peripheral blood samples were collected. In order to obtain blood samples from 
young children, EMLA cream 5% (AstraZeneca, Macclesfield, UK) was applied 
to the skin for one hour prior to venepuncture. Blood sample tubes were 
accurately labelled and stored at 4°C until DNA extraction took place.
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2.1.5 DNA extraction and storage
In general, DNA was extracted not more than one week after blood samples were 
collected. Extraction was carried out by laboratory technicians using the Nucleon 
BACC2 kit (Tepnel Life Sciences PLC, Manchester, UK). After extraction, DNA 
was stored at 4°C if for immediate use or at -20°C if for longer term storage.
2.2 Genotyping
2.2.1 Family panel creation
For each large cataract family, a family panel was created. DNA from each 
available family member was stored in numbered wells of a deep-well plate at 
4°C. Once the optimum DNA concentration for polymerase chain reaction (PCR) 
was established using positive control DNA, the family panels were made up, 
diluting the DNA to this optimum concentration. The original DNA 
concentrations were measured using an Eppendorf Biophotometer version 1.26 
spectrophotometer (Eppendorf, Hamburg, Germany). The samples were then 
diluted in the deep wells with deionised water to the optimum DNA 
concentration, which was found to be 25ng/pl. Finally, the family DNA panel was 
tested by performing PCR on the panel and examining the size and intensity of 
each product band after agarose gel electrophoresis.
2.2.2 Polymerase chain reaction (PCR)
PCR for genotyping was carried out using the following standard reaction 
mixtures:
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Table 2 PCR reaction mix for separate forward (FP) and reverse primers (RP)
Mix for 10 
reactions
lOxNHU
buffer
dNTP
25mM
MgCl2
50mM
FP
20pM
RP
20pM
Taq
5U/1
dH20 DNA
+ mix
Volume / pi 25 2 6 3 3 1 2 0 0 2  + 2 0
Table 3 PCR reaction mix for combined primers
Mix for 10 
reactions
IOXNH4
buffer
dNTP
25mM
MgCl2
50mM
Primer
5pM
Taq
5U/1
dH20 DNA 
+ mix
Volume / pi 2 0 1.6 6 10 1 2 0 0 2  + 2 0
The components were mixed together before finally adding 2pi of each panel 
DNA to 20pl of reaction mixture.
PCR was carried out on Techne Touchgene gradient PCR blocks (Jencons, 
Leighton Buzzard, UK). After initial denaturation at 95°C for three minutes, 
samples were processed through 35 cycles of amplification consisting of 30 
seconds at 92°C (denaturing), 30 seconds at the optimum annealing temperature 
for the particular primers, typically 55°C (annealing) and 30 seconds at 72°C 
(extension). The final extension step at 72°C was lengthened to 5 minutes.
When genotyping was performed using primers from the ABI PRISM linkage 
mapping set version 2.5 (Applied Biosystems, Warrington, UK), an annealing 
temperature of 55°C was used in the first instance. When other primers were used, 
the optimum annealing temperature was first established with control DNA by
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performing PCR at a gradient of temperatures and assessing the size and intensity 
of the products on an agarose gel.
2.2.3 Agarose gel electrophoresis
1% agarose gels were prepared, adding a few drops of 0.5mg/ml ethidium 
bromide prior to pouring the gels. Gel electrophoresis was performed, after which 
PCR products were visualised and compared against standard DNA ladders in the 
Gene Genius gel imaging system (Syngene, Cambridge, UK) using Genesnap 4.0 
software (Syngene). A qualitative assessment of the amount of DNA in each PCR 
product was made by comparing the size and intensities of the bands on the gel. A 
quantitative estimation of the amount of DNA was made where appropriate by 
comparing PCR product bands with those of a quantitative DNA ladder.
2.2.4 Genotyping
Fluorescently labelled microsatellite markers were used to perform PCR on family 
DNA panels. The PCR products were loaded onto an ABI PRISM 3100 genetic 
analyser (Applied Biosystems) which was configured for genotyping. Automated 
allele scoring was achieved using Genotyper software version 3.7 (Applied 
Biosystems). A typical genotyping tracing is shown in Appendix 6.1 The alleles 
were entered into the pedigrees using Cyrillic software. Two point LOD scores
10Rwere calculated using the FASTLINK package.
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2.2.5 Genotyping strategies
Both whole genome scanning and exclusion of known cataract loci were used to 
establish linkage. PCR products were pooled to allow simultaneous multiple 
marker analysis by the genotyper. On average, a family panel was genotyped with 
three or four markers every day.
2.2.6 Primers used for genotyping
Fluorescently labelled microsatellite primers from the ABI linkage mapping set 
version 2.5 were used for whole genome scanning and, where possible, for 
candidate loci exclusion. When a known cataract locus was not excludable using 
an ABI marker, the Ensembl database (EMBL-EBI and Sanger Institute, both 
Cambridge, UK) at www.ensembl.org was used to search for alternative adjacent 
microsatellite markers. The Ensembl database was also used when selecting 
markers for refining a region of linkage.
2.3 Sequencing
2.3.1 PCR
PCR was performed to amplify the region of DNA to be sequenced. The same 
PCR block settings as described above were used. A pre-prepared PCR reaction 
mixture, ReddyMix PCR master mix (Abgene, Epsom, UK), was used.
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Table 4 PCR reaction mixture for sequencing
Mix for 1 
reaction
ReddyMix dH20 FP
20pM
RP
20pM
DNA
Volume / pi 2 0 2 0 1 1 2
PCR was performed at the optimum temperature for the particular pair of primers. 
The product was checked on a 1% agarose gel. The next stage of sequencing was 
to clean the PCR product.
2.3.2 PCR product clean up
DNA was extracted from PCR product using the Quickstep 2 PCR purification kit 
(Edge Biosystems, Gaithersburg, MD, USA). The DNA was then cycle 
sequenced.
2.33  Cycle sequencing
Big Dye Terminator Ready Reaction Mix (Applied Biosystems) was used for 
cycle sequencing.
Table 5 Reaction mix for cycle sequencing
Mix for 1 
reaction
dH20 Buffer Big
dye
Primer
20pM
DNA
Volume /pi 4.3 2.5 0.5 0.7 2 .0
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A standard cycle sequencing program on the PCR blocks was used. After initial 
denaturation at 95°C for three minutes, samples were processed through 25 cycles 
consisting of ten seconds at 96°C, five seconds at 50°C and four minutes at 60°C. 
The sequenced product was then cleaned.
2.3.4 Sequenced product clean up
Several steps were involved in cleaning up the sequenced product, lp l of sodium 
acetate was added to precipitate the buffer. 25pi of 1 0 0 % ethanol was added to the 
mixture, before freezing it at -20°C for 10 minutes. It was then centrifuged at 
13000 rpm for 20 minutes. 300pl of 70% ethanol was added, before centrifuging 
again at 13000rpm for 20 minutes. The supernatant was carefully removed, 
leaving a pellet at the bottom of the tube. The tube was oven dried at 60°C for 10 
minutes to leave a completely dry pellet. The pellet was thoroughly mixed in lOpl 
of formamide, before loading the mixture onto an ABI PRISM 3100 Sequencer 
(Applied Biosystems).
2.3.5 Sequence analysis
DNA sequencing analysis software version 3.7 (Applied Biosystems) was used to 
view the sequences. The following programmes in the DNAstar Lasergene 
software package were used to analyse the sequences: EditSeq, Seqman II and 
MapDraw.
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2.3.6 Primers
The entire coding region of the connexin 46 gene (CX46) was sequenced using the 
same pairs of overlapping primers as used by Jiang et al:32
Table 6 Primers for sequencing CX46
Primer name Primer sequence
GJA31AF
GJA31AR
CTGCGATGCCTGTCCTGTGG
TTGTCCTGCGGTGGCTCCTT
GJA31BF
GJA31BR
CGCCCACCCTCATCTACCT
GTGGGAACCCGATGGCAAC
GJA31CF
GJA31CR
AGCTCAAGCAGGGCGTGACC
CAAGGGCGGCTGGTGCATCT
GJA31DF
GJA31DR
CCCCGGCGCTCAAGGCTTAC
AACCCTTGTCCCCGCCACCC
2.4 Construct preparation for expression studies
Once a mutation in the connexin 46 gene (CX46) was found to segregate with 
ADCC in a large family, constructs were prepared to investigate the effect of this 
mutation on connexin 46 protein (Cx46) expression in connexin-deficient human 
lymphocyte HeLa cells. Wild type and mutant CX46 inserts and a wild type CX50 
insert were amplified from genomic DNA and then cloned into a mammalian 
expression vector pTARGET (Promega, Southampton, UK). To prepare fluorescent 
fusion protein constructs, wild type and mutant CX46 inserts were first cloned into 
pGEM-T Easy vector (Promega) and then subcloned into a C-terminal tagged 
green fluorescent protein (GFP) mammalian expression vector pEGFP-Nl 
(Invitrogen Clontech, Paisley, UK). Vector diagrams are shown in Appendix 6.2.
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2.4.1 Wild type CX46 construct 
2A1.1 PCR
After determining the optimum temperature for PCR using control DNA, the 
entire CX46 gene was amplified using DNA from an unaffected individual from 
the family. ATGGGCGACTGGAGCTTTCTGGGAAGAC was used as the 
forward primer. The reverse primer used was CTAGATGGCCAAGTCCTCCG. 
The same PCR reaction mixture and block settings were used as described for 
PCR for sequencing above. However, since the size of the PCR product in this 
case was 1.3kilobases (1.3kb), the extension phase of each cycle was lengthened 
to one and a half minutes.
2.4.1.2 Gel purification of PCR product
The PCR product was run on a 1% low melting temperature agarose gel with both 
a lkb and a lOkb ladder in order to separate the DNA from the other components. 
The 1.3kb band was briefly visualised with ultraviolet light before being cut out of 
the gel. This band of DNA was further purified using the QIAquick gel extraction 
kit (Qiagen, Crawley, UK).
2.4.1.3 Estimation of purified insert concentration
5 pi of purified insert was run on a 1% agarose gel with a lOkb ladder to estimate 
the DNA concentration of the insert. The insert concentration was estimated as 
30ng/pl.
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2.4.1.4 Ligation
A 3:1 insert:vector molar ratio was used. The following equation was used to 
calculate the appropriate amount of insert to include in the ligation reaction:
((ng of vector x kb of insert)/kb size of vector) x insert:vector molar ratip = ng 
((60 x 1.3)/5.67) x 3 = 41ng of insert
Since the estimated insert concentration was 30ng/pl, 1.5 pi of insert was used. 
Positive control and background control ligations were also performed so that the 
following ligation reactions were set up and incubated overnight at 4°C:
Table 7 Ligation reaction mixtures
Volume / pi Construct
reaction
Positive
control
Background
control
T4 DNA ligase lOx buffer 1 1 1
pTARGET vector (60ng) 1 1 1
Purified PCR product 1.5 - -
Control insert DNA (8ng) - 2 -
T4 DNA ligase (3 Weiss 
units/pl)
1 1 1
Deionised water 5.5 5 7
2.4.1.5 Transformations
The ligation reactions were transformed into separate tubes of high-efficiency 
JM109 cells (Promega). These cells were then plated onto pre-prepared agar 
plates, which were incubated overnight at 37°C.
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2.4.1.6 Agar plate preparation
One litre of Lucia Broth (LB) agar was prepared by adding deionised water to the 
following constituents:
lOg tryptone (Fisher Scientific UK Limited, Leics, UK)
5g yeast extract (Oxoid Limited, Basingstoke, UK)
lOg analytical reagent grade sodium chloride (Fisher Scientific UK Limited)
15g agar number 1 (Oxoid Limited)
The solution was heated in an autoclave at 121°C for approximately 2 hours, until 
it was homogeneous. It was then air cooled until its temperature was 
approximately 50°C. 1ml of each of the following filter sterilised solutions were 
then added to the agar: 
ampicillin (50mg/ml) (Sigma, Poole, UK)
X-gal (Sigma) 20mg/ml in dimethyl formamide
IPTG (lOOmM) (Gold Biotechnology, Inc., St. Louis, MO, USA).
In a laminar box, the LB/ampicillin/IPTG/X-Gal solution was poured into sterile 
Petri dishes to a thickness of 5-7mm. Once set, plates were either used directly or 
stored at 4°C for later use.
2.4.1.7 Colony selection
After overnight incubation, the plates were examined. The pTARGET vector 
contains a modified version of the coding sequence of the a-peptide of p- 
galactosidase, allowing blue/white recombinant screening. Successful cloning of 
an insert into the pTARGET vector interrupted the coding sequence of the a- 
peptide of P-galactosidase, causing colonies to appear white. These colonies were
62
easy to distinguish from blue colonies of vector alone, in which the coding 
sequence was uninterrupted. The positive control plates indicated whether or not 
transformation had worked and showed the efficiency of ligation. The background 
control plates allowed determination of the number of colonies resulting from 
vector self-ligation or undigested vector.
2.4.1.8 Preparing plasmids
White colonies from the wild type construct plates were picked and separately 
incubated overnight at 37°C with agitation in labelled tubes containing LB with 
50mg/ml ampicillin. The following day the Genelute plasmid minprep kit (Sigma) 
was used to purify plasmids from each tube. In the final stage of plasmid 
preparation, the plasmids were eluted into 50pl of sterile lxTris-EDTA buffer at 
pH 7.0. 50pl of the same plasmid was then eluted using sterile deionised water. 
The plasmid in deionised water was used for sequencing.
2.4.1.9 Sequencing plasmids
Plasmids were first sequenced with the forward sequencing primer recommended 
for pTARGET, TAATACGACTCACTATAGGG, to determine which ones had the 
insert in the correct orientation. Only these plasmids were fully sequenced to 
check for differences in sequence between the plasmid and the known CX46 
sequence. Sequencing was performed on the purified plasmids as described above 
from the cycle sequencing stage onwards. Two modifications were made. In the 
PCR program for cycle sequencing, the initial denaturation at 95°C was 
lengthened to five minutes. Secondly, 4pl of plasmid DNA was used instead of
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2 |nl of purified PCR product DNA. The volume of water was reduced so as to 
keep the total reaction mixture volume the same. For sequencing the entire CX46 
gene, further primers were used including the reverse sequencing primer 
recommended for pTARGET, TTACGCCAAGTTATTTAGGTGACA, a forward 
internal sequencing primer, GTCCCTATTCCTCAACGTG, and a reverse internal 
sequencing primer, CACGTTGAGGAATAGGGAC.
2.4.1.10 Estimation of construct concentration
Once a plasmid was identified which consisted of wild type CX46 correctly 
cloned into pTARGET, its concentration was estimated. A 1% agarose gel was 
prepared for gel electrophoresis to run various dilutions of the construct plasmid 
against known concentrations of Lambda DNA (Promega), a control plasmid (See 
Figure 2). The band of the 1:20 dilution of construct plasmid was roughly equal in 
size and intensity to that obtained with lOOng of Lambda DNA. Since lOpl of 
construct plasmid was loaded, the construct plasmid concentration was estimated 
as 2 0 0 ng/pl.
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Figure 2 Picture of 1% agarose gel used for estimating insert concentration
100 200 300 400 500 1:40 1:20 1:10
ng of Lambda DNA dilutions o f construct plasmid
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2.4.1.11 Glycerol stocks
A small volume of the overnight culture which had been used to prepare the 
plasmid was used to prepare a glycerol stock. 300pl of sterile 50% glycerol was 
mixed with 700pl of overnight culture in a cryovial. The cryovial was stored at 
-80°C.
2.4.2 Mutant Cx46 construct
The same cloning process was used to prepare a construct consisting of mutant 
CX46 cloned into pTARGET. This time, however, the DNA used to prepare the 
insert was from an affected individual and the forward primer used for the initial 
PCR was ATGGGCTACTGGAGCTTTCTGGGAAGAC. When the insert 
sequence was checked, only those plasmids with the mutation present were 
selected for full CX46 gene sequencing.
2.4.3 Wild type Cx50 construct
The forward primer, ATGGGCGACTGGAGTTTCCTGGGGAAC, and the 
reverse primer, TCATACGGTTAGATCGTCTGAC, were used to prepare the 
insert from an unaffected individual’s DNA. The cloning process was otherwise 
the same as that for wild type Cx46 construct.
2.4.4 Fluorescent fusion protein constructs
To prepare fluorescent fusion protein constructs, PCR products of the entire CX46 
gene were first cloned into pGEM-T Easy vector (Promega) and then subcloned
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into pEGFP-Nl vector (BD Biosciences Clontech, Oxford). The primers used for 
creating the wild type insert for pGEM-T were forward primer 
AAGCTTATGGGCGACTGGAGCTTTC and reverse primer 
GGATCCTTGATGGCCAAGTCCTCCG. The same reverse primer was used for 
creating the mutant insert. The forward primer used for this was 
AAGCTTATGGGCTACTGGAGCTTTC. Subcloning was achieved by 
performing double digests on the PGEM-T constructs and on the pEGFP-Nl 
vector using Hind III and Bam HI restriction enzymes (both Promega). The 
double digests on the PGEM-T constructs were performed by incubating the 
following reaction mixtures at 37°C for 4 hours.
Table 8 Double digest reaction nurtures for PGEM-T Easy vector construct
dH20 lOx buffer BSA
ing/jti
Construct DNA 
400ng/pl
Hind HI Bam HI
Volume / pi 11 2 2 3 1 1
Hie double digest on the pEGFP-Nl vector was performed by incubating the 
reaction mixture at 37°C for 15 minutes and then at 65°C for 15 minutes to 
inactivate the shrimp alkaline phosphatase (SAP) (Promega). SAP 
dephosphorylated the vector in order to prevent self-ligation.
Table 9 Double digest reaction mixture for pEGFP-Nl vector
dH20 lOx buffer BSA
lpg/pl
Vector
lpg/pl
Hind III Bam HI SAP
lu/pl
Volume / pi 10 3 3 1 1.5 1.5 10
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After the double digests, the mutant and wild type inserts were gel purified. Their 
concentrations and that of the digested dephosphorylated vector were estimated on 
a 1% agarose gel before the inserts were each ligated into the vector using a 3:1 
insertivector ratio. Positive control and background control ligations were 
performed as before. Transformants were plated onto agar plates containing 
kanamycin (50mg/ml) (Sigma, St. Louis, MO, USA) instead of ampicillin because 
pEGFP-Nl vector is resistant to kanamycin unlike pTARGET vector which is 
ampicillin-resistant. Since pEGFP-Nl vector does not allow blue/white colony 
selection, colonies were screened for successful cloning of the insert into pEGFP- 
N1 by carrying out colony PCR using GJA31CF and GJA3 ICR primers at their 
optimum temperature of 55°C. Plasmid minipreps were prepared using colonies 
which contained the inserts. These plasmids were sequenced to confirm that the 
fusion protein sequences were correct. A wild type fusion protein construct 
(CX46-GFP) and a mutant fusion protein construct (D3 Y-GFP) were prepared and 
glycerol stocks of them were prepared and stored as described above.
2.5 Protein expression studies: localisation
Human HeLa cells were cultured for forty-eight hours in culture medium 
comprising 88.5% DMEM (Sigma), 10% foetal calf serum (Labtech, Ringmer, 
UK), 0.5% penicillin lOOU/ml (Sigma), 0.5% streptomycin lOOpg/ml (Sigma) and 
0.5% fungizone 1.25pg/ml (Sigma). The cultures were incubated at 37°C in 5% 
CO2. The cells were then seeded onto coverslips at a density of approximately 
50% for twenty-four hours prior to transfection. Connexin 46 wild type (cx46wt), 
connexin 46 mutant (cx46mt), CX46-GFP and D3 Y-GFP constructs and positive 
control CX26-GFP construct77 (a gift from D.L. Becker) were transfected into
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adherent human HeLa cells using EfFectene transfection reagent (Qiagen). Cells 
were cultured for a further twenty-four hours. Those cells transfected with GFP 
construct were visualised directly at this stage using a Leica DMLB fluorescence 
microscope with water-dipping lenses (Leica Microsystems, Milton Keynes, UK). 
Images were digitally recorded with a Leica DCF300 camera. Those cells 
transfected with cx46wt or cx46mt constructs were fixed with 4% 
paraformaldehyde and immunostained. Fixed HeLa cells were briefly rinsed with 
phosphate-buffered saline (PBS, pH 7.4) and then immersed in blocking solution 
(lOOmM L-lysine in lxPBS with 0.05% Triton X-100) at room temperature for 
one hour. Cells were then incubated with primary rabbit antibodies against Cx4672 
(a gift from T.W. White) diluted 1:1000 in blocking solution at 37°C for one hour. 
Following three five minute washes with PBS, cells were incubated with 1:500 
CY3, rhodamine-conjugated goat anti-rabbit IgG (Zymed, San Fransisco, CA, 
USA), in blocking solution at 37°C for one hour. After three further five minute 
washes with PBS, preparations were mounted in Citifluor (Canterbury,UK) on 
slides and sealed with nail varnish. Slides were examined on a Leica fixed stage 
epifluorescence microscope and on a Leica SP2 laser scanning confocal 
microscope and images were stored digitally.
2.6 Protein expression studies: function
Dye injection studies were carried out using glass micropipettes pulled from thick 
walled borosilicate capillary glass (Harvard Apparatus, Holliston, MA, USA) with 
a Sutter Instruments horizontal pipette puller (Novato, CA, USA). Coverslips of 
HeLa cells expressing GFP were transferred into larger dishes containing 
Neurobasal medium (Gibco, Rockville, MD, USA). The cells were visualised on a
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Leica DMLFS fixed stage epifluorescence microscope using water-dipping lenses 
so that pairs or groups of GFP positive cells could be selected for microinjection. 
Single cells from each group were iontophoretically injected with a mixture of 5% 
lucifer yellow (Sigma) and 2% neurobiotin (Vector, Peterborough, UK). Cells 
were observed for two minutes for intercellular passage of lucifer yellow.
Relevant images were recorded digitally with a Leica DCF300 camera. To reveal 
the distribution of neurobiotin, preparations were fixed with 4% 
paraformaldehyde, permeabilised and blocked with lOOmM L-lysine in lxPBS 
with 0.05% Triton X-100 for one hour and then stained with 1:200 Avidin-CY3 
(Zymed) in blocking solution for thirty minutes. Fluorescent signals were 
examined on a Leica DMLB fluorescence microscope and images were stored 
digitally using a Leica DCF300 camera.
70
3.0 Results
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3.1 Phenotyping and linkage studies in two large families
3.1.1 Phenotyping
Two large English Caucasian families with ADCC were identified from the 
genetic clinic database at Moorfields Eye Hospital. The pedigrees are shown in 
Figures 3 and 4. AD inheritance is supported in both families by the presence of 
affected male and female individuals in each generation and male-to-male 
transmission. Previously, the families were predominantly phenotyped for cataract 
and other clinical abnormalities. The affected proband from family A (subject 
111:5), a 41 year-old female, was re-phenotyped as part of this study. She had a 
unique phenotype for her family comprising PPC and ASMD. Her most recent 
operation under general anaesthetic was digitally recorded to aid phenotyping 
since it allowed more accurate assessment than was possible when she was awake 
due to her nystagmus. Her unaffected son (IV:5) was re-phenotyped in the light of 
her unusual phenotype. Her affected eight year-old daughter (IV:6 ) and affected 
fifteen year-old niece (IV:7), who had both not been phenotyped previously, were 
also examined. Blood samples were collected for DNA extraction from all of 
these individuals. Phenotyping and blood sample collection was performed on 
three individuals from family B. An affected 35 year-old mother (IV: 11) and her 
two children, an affected seven year-old daughter (V:3) and an unaffected eleven 
year-old son (V:4), were examined. By seeing the affected daughter (V:3), the 
family’s phenotype was defined since the phenotype was progressive and so in 
order to define it accurately, it was important to see it in its early stages.
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Figure 3 Pedigree A.
Square symbols denote males; circles denote females; affected individuals are denoted by 
black symbols.
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3.1.2 The phenotype
Overall, the age ranges of the individuals examined were: eight to seventy (family 
A) and seven to eighty (family B). All affected individuals from the two families 
had the same cataract phenotype. PPC was fully penetrant but exhibited some 
variable expressivity. Typically, bilateral posterior polar cataracts were present 
from birth, gradually progressed, became clinically significant within the first 
decade of life and visually significant within the first two decades, necessitating 
cataract extraction and lens implantation (Figures 5 a and b). In family A, one of 
ten affected individuals (subject 111:5) had ASMD in addition to cataract. This 
subject had, in addition to cataracts, congenital glaucoma, posterior embryotoxon, 
atrophic irides and microcomea. She underwent a left penetrating keratoplasty 
aged 28 and repeat penetrating keratoplasty aged 41 for endothelial 
decompensation in the previous graft (Figures 5 c and d). There were no other 
ocular or systemic abnormalities in individuals from either family. Visual acuities 
were recorded for all the individuals examined in this thesis. In family A, the 
visual acuities of the affected individuals were: 3/60, 6/60 for the pseudophakic 
individual 111:5 with PPC and ASMD, 6/18, 6/12 for her fifteen year-old niece 
(IV:7) and 6 /6 , 6 /6  for her eight year-old daughter (IV:6 ). In family B, the visual 
acuities of the affected individuals were 6/9, 6/9 for a pseudophakic thirty-five 
year-old mother (IV: 11) and 6/9,6/9 for her seven year-old daughter (V:3).
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Figure 5 Family A phenotypes
(a) Direct illumination and (b) retroillumination slit lamp photographs o f posterior polar 
cataract in individual IV:7 from family A. (c) Right and (d) left eyes o f subject 111:5 from  
family A at the end o f repeat left penetrating keratoplasty.
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3.1.3 Linkage studies
Initial linkage analysis was previously performed for family A. After excluding 
the following candidate loci for PPC: lp36, 11 q21 and 20pl2, whole genome scan 
had revealed a significantly positive two-point LOD score (3.61 at recombination 
fraction, 0, of 0) for the marker DIOS 192. In this thesis, the region of linkage was 
refined. Using markers from the ABI linkage mapping set version 2.5 and other 
specifically ordered markers in the region, maximum two-point LOD scores of 
3.61 at 0=0 were obtained at seven other markers in the region including D10S564 
and D10S597. The linked region was refined by demonstrating flanking 
crossovers with an upper crossover at DIOS 1686 and a lower crossover at 
DIOS 1693 (See Figure 6 ). This region encompassed the PITX3 gene. Appendix
6.3 shows a LOD score table for the region.
Whole genome scan of family B had previously indicated possible linkage to the 
long arm of chromosome 10. In this thesis, the tentative linkage was supported 
using multiple markers around the PITX3 gene, including those shown in Figure 
7. A maximum two-point LOD score of 2.58 at 0=0 was obtained for marker 
DIOS 1739. Haplotyping suggested that families A and B are unrelated. For 
example, for marker DIOS 192, the disease haplotype in family A is allele 4, 
whilst in family B it is allele 5.
Direct sequencing, undertaken by Dr Berry,22 demonstrated that all affected 
individuals in both families had an identical mutation in the PITX3 gene (shown 
in Appendix 6.4) and that this mutation was absent in unaffected individuals and 
100 normal controls. Sequence analysis of the gene revealed a 17 bp duplication
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Figure 6 Family A with haplotype data shown
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mutation in exon 4 which segregated with the disease phenotype in the two 
families. The mutation results in a frameshift in codon 220 and leads to the 
production of an aberrant protein consisting of 94 additional residues.
3.2 Linkage studies in large family from Honduras with 
ADCC
3.2.1 The pedigree and phenotype
The family, shown in Figure 8, was obtained as part of a collaboration with Dr 
Anand Srivastava of the Greenwood Genetic Centre, SC, USA. Phenotyping was 
essentially conducted by clinical colleagues from the Greenwood Genetic Centre. 
Twenty-six DNA samples were obtained from the five-generation family (Figure 
8) from Honduras with ADCC. AD inheritance is supported by the presence of 
affected individuals in each of the five generations, equal numbers of affected 
males and females and male-to-male transmission. The phenotype is shown in 
Figure 9. Zonular pulverulent cataract was fully penetrant and exhibited some 
variable expressivity. There were no other ocular or systemic abnormalities. 
Bilateral zonular pulverulent cataracts typically presented in the first few months 
of life and progressed to total opacity over time. Snellen visual acuities of affected 
individuals at diagnosis ranged from 6/18 to 1/60. In many cases, there was 
amblyopia. To date, almost all of the affected individuals have had cataract 
surgery. After receiving the DNA samples, molecular genetic and functional 
studies were performed.
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3.2.2 Genotyping
Twenty-six members of the family, including sixteen affected individuals and ten 
unaffected individuals, were genotyped. Initially, the only clinical information 
provided by our collaborators was that affected individuals in the family had 
ADCC. The phenotype was not described. Therefore, whole genome scan was 
begun since linkage to a known or a novel cataract locus was possible and there 
were no phenotypic clues to suggest which known loci to screen. Whole genome 
scan began with chromosome 1. After a total of twenty-eight markers were used, 
the whole of chromosome 1 was excluded in terms of linkage. Since whole 
genome scan was time-consuming, it was decided to change strategy and exclude 
known cataract genes on other chromosomes by genotyping using markers close 
to these genes. Several candidate genes implicated in ADCC were excluded by 
linkage analysis (LOD scores less than 1 at 0=0) including CX50, CRYGC, 
CRYGD, BFSP2, M P  and PITX3. At this stage, our clinical collaborators sent 
more information on the phenotype. Since the phenotype was zonular pulverulent 
cataract, the priority changed to excluding genes known to be associated with this 
phenotype. CX50 had already been excluded. CX46, known to be associated with 
zonular pulverulent cataracts, was investigated next. The family was genotyped 
using marker D13S175, adjacent to the CX46 gene. A maximum two-point LOD 
score of 2.53 was obtained at 0=0 for D13S175. The LOD score was not above 3 
since this marker was relatively uninformative in the family. All the other markers 
in this region from the ABI linkage mapping set version 2.5 were used in an 
attempt to find a more informative marker for this family. The family was 
genotyped using D13S1236, D13S1316, D13S1275, D13S1243, D13S1304,
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D13S217 and D13S292. These markers were also relatively uninformative in the 
family. Maximum two-point LOD scores of 1.03 at 0=0 and 1.58 at 0=0.05 were 
obtained for markers D13S1316 and D13S292 respectively. The LOD score table 
is shown in Appendix 6.5. Haplotyping refined the region of possible linkage 
(Figure 8) as being between the tip of chromosome 13q above and the marker 
D13S1275 (the lower crossover) below. It was decided that the LOD score of 2.53 
for marker D13S175 together with correlation between the family’s phenotype 
and the phenotype typical of cataracts associated with CX46 mutations warranted 
screening of this gene.
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Figure 8 Abbreviated pedigree for family C
Square symbols denote males; circles denote females; affected individuals are denoted by 
black symbols. Haplotype data is shown.
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Figure 9 Typical zonular pulverulent cataract from family C
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3.3 Identification of a novel mutation in CX46
The entire CX46 gene (GenBank reference NM 021954) was directly sequenced 
in an affected and an unaffected individual from family C. Both the affected and 
the unaffected individual differed from the published sequence in the following 
way. Nucleotide 895 was an adenine (A) in these individuals instead of a cytosine 
(C) in the published sequence. This changed the codon from CTG which codes for 
leucine to ATG which codes for methionine. This is, in fact, a known single 
nucleotide polymorphism (SNP) in this gene.
The affected individual differed from the published sequence in another way. At 
nucleotide 7, the affected individual had a T instead of a G (See Appendix 6.6). 
This mutation changes the amino acid encoded by the third codon from a 
negatively-charged amino acid aspartate (D) to an uncharged amino acid tyrosine 
(Y). This variant 7G>T, causing a novel heterozygous missense mutation D3Y, 
was identified by direct sequencing in all 16 affected individuals but in none of 10 
unaffected individuals from the family nor 106 control chromosomes from a 
control panel in our laboratory. Additionally, our collaborators in America tested 
for the mutation and found it was absent in 124 control chromosomes (32 
Hispanic, 70 white, 16 black and 6 unknown). The tyrosine residue is conserved 
across species represented in GenBank (Figure 10) and in other related connexins 
(Appendix 6.7).
The D3 Y mutation is likely to be causative since it segregates with affected status 
throughout the pedigree and is absent both in unaffected individuals within the 
pedigree and in unaffected, unrelated controls. The mutation results in a
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Figure 10 Cross species alignment of Connexin 46
Alignment of residues 1-60 of human Cx46 with mouse, rat and zebra fish {Danio rerio) 
orthologues is shown. D3 is boxed.
H um an MG! > iriSFL GRLLE HAQEHS TV IGKVWL TVLFIFRILVLGAAAE DVWGD EQS DF TCHTQQPG 
M o u se  MG! >»SFLGRLLEHAQEHSTVIGKVWL TVLFIFRILVLGAAAEEVWGDEQSDFTCHTQQPG 
R a t  MG! > WSFL GRLLE HAQEHS TVIGKVWLTVLFIFRILVLGAAAEEVWGD EQS DF TCHTQQPG
D a n io  MG1 > FSSL GKLLE SAQEHS TVVGKVWLTVLFIFRILVLSAAAE KVWGDEQS GF TCDTKQPG
83
significant amino acid substitution, changing a negatively-charged amino acid to 
an uncharged amino acid close to the amino terminus of the protein.
3.4 Phenotyping and screening for the D3Y mutation in 
another family with ADCC
Three affected individuals (111:2, IV:2 and V :l) from a five-generation English 
Caucasian family with AD zonular pulverulent cataract, family D, were 
phenotyped and blood samples were collected for DNA. The pedigree was 
ascertained through the cataract clinic at Great Ormond Street Hospital (Figure 
11). All three individuals had bilateral cataracts from birth. However, there was 
some intrafamilial variation in cataract severity. Subject IV:2 had cataract surgery 
on both eyes within her first year of life. Her son, aged three, subject V: 1, had 
mild cataracts and had not yet undergone surgery.
The entire CX46 gene was sequenced using DNA from individual IV:2. This 
individual also had the SNP at position 895 (resulting in a leucine to methionine 
change), as previously seen in the two individuals from the Honduran family. 
However, there were no other sequence variations anywhere in the gene. DNA 
from an affected member of this family has therefore been added to the cataract 
panel for candidate gene screening.
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Figure 11 Family D pedigree
Square symbols denote males; circles denote females; affected individuals are denoted by 
black symbols.
<!> <!><!> i  i  ^ o-A i  i  0
ii
in
IV
V
1 2 3 4  5 6 7 8
□-rA 1-rHO 1  O
1 I 2 3 I 4  5 6
□ . iA  (!) 4-rO A t o  io-r-i
1 ^ 2 3  4^  5 I 6  ^ 7 8 10 11 ^  12
A A i-r-a
A
7 8 9
1
13 14
85
3.5 Protein expression studies on D3Y mutation - 
locaiisation
The following construct plasmids were successfully prepared for expression 
studies:
1. wild type CX46 in pTARGET vector (cx46wt)
2. mutant CX46 in pTARGET vector (cx46mt)
3. wild type CX46 in pEGFP-N 1 vector (CX46-GFP)
4. mutant CX46 in pEGFP-Nl vector (D3Y-GFP)
5. wild type CX50 in pTARGET vector (cx50wt)
Human HeLa cells were transiently transfected in separate experiments with the 
first four constructs above containing CX46. GFP expression was observed for 
cells transfected with either CX46-GFP or D3Y-GFP at points of contact between 
adjacent cells. This indicated appropriate trafficking of the protein and the 
formation of gap junction plaques between neighbouring transfected cells (figures 
12 a and b). For cx46wt and cx46mt constructs, immunolabelling with an 
antibody specific to connexin 46 protein (Cx46) revealed Cx46 at points of 
contact between adjacent cells. GFP tagging had clearly not interfered with the 
protein trafficking (figures 12 c and d). Wild type and mutant connexins both 
trafficked to the membrane in a similar way. It was anticipated that, time 
permitting, Cx46 and Cx50 constructs would be co-expressed to mimic the 
situation in vivo. However, due to time constraints, these experiments were not 
possible.
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Figure 12 Cx46 localisation
CX46-GFP (A), D3Y-GFP (B), Cx46wt (C) and Cx46mt (D) proteins all traffic to the 
membrane to form plaques between cells. The GFP labelled protein appears green whilst the 
latter two proteins are immunostained red using a rhodamine-conjugated secondary 
antibody.
3.6 Protein expression studies on D3Y mutation -  function
Dye injection studies were performed on cells transfected with CX46-GFP, D3Y- 
GFP and CX26-GFP (a gift from D.L. Becker) plasmids in separate experiments. 
All ten CX26-GFP transfected cells injected with a mixture of lucifer yellow and 
neurobiotin exhibited lucifer yellow dye transfer to adjacent transfected cells 
within two minutes. None of ten CX46-GFP transfected cells or ten D3Y-GFP 
transfected cells exhibited such intercellular transfer with either lucifer yellow or 
the smaller molecule neurobiotin. These results are summarised in Figures 13 and 
14.
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Figure 13 Intercellular transfer studies I
Lucifer yellow dye injected into a CX26-GFP transfected cell with an intercellular plaque 
(A) transfers to the transfected cell above (B) within 2 minutes o f injection. No such 
intercellular dye transfer is seen for cx46wt transfected cells (C, D) or for cx46mt transfected
Figure 14 Intercellular transfer studies II
Following dye injection, Fixing and staining with Avidin-CY3 to localise neurobiotin, neither 
lucifer yellow nor neurobiotin was shown to have been transferred between adjacent coupled 
cx46wt (A, B) or cx46mt (C, D) transfected cells.
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3.7 Cataract panel
DNA from twenty-one affected individuals from different families with inherited 
cataract was added to our existing cataract panel. The families were ascertained 
through several sources, predominantly the cataract clinic at Great Ormond Street 
Hospital and the genetic clinic at Moorfields Eye Hospital. All of the individuals 
added to the panel were phenotyped as well as many of the other individuals in 
these small families -  affecteds, unaffecteds and married-in individuals. Blood 
samples for DNA were obtained from those individuals who gave their consent. 
The pattern of cataract inheritance in 90% (19/21) of these mainly small families 
was AD. Two families, both of which had consanguineous unaffected parents, 
demonstrated AR inheritance. In many cases, it was not possible to record the 
cataract phenotype because all the available affected individuals had already 
undergone cataract surgery and the cataract phenotype was not accurately 
documented in the hospital notes. However, thirteen of these twenty-one families 
had a determinable cataract phenotype. Four of these families had PPC, one of 
which also had ASMD. This family was investigated but not found to have a 
mutation in the PITX3 gene, an obvious candidate gene for PPC and ASMD.
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Table 10 Summary of the panel families
Inheritance
pattern
Cataract
phenotype
Number 
of families
AD APC 1
AD PPC 3
AD PPC + ASMD 1
AD Nuclear pulverulent 3
AD Zonular pulverulent 2
AD Nuclear 2
AD Unknown phenotype 7
AR PPC 1
AR total 1
The pedigrees of these twenty-one families are illustrated in the figures on the 
following pages, together with relevant photographs from some of the families.
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Figure 15 Panel family 1
Figure 16 Panel family 2 
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Figure 18 Panel family 4
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Figure 19 Panel family 5
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Figure 20 Panel family 6
Figure 21 Panel family 6 phenotype
Right eye of subject 11:2 from panel family 6, showing the nuclear pulverulent cataract 
phenotype typical o f affected individuals in the family
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Figure 22 Panel family 7
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Figure 27 Panel family 12
Figure 28 Panel family 13
Figure 29 Panel family 14
Figure 30 Panel family 15
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Figure 31 Panel family 16
IV: 1
Figure 32 Panel family 16 phenotype
Diffuse illumination (A) and slit beam view (B) o f nuclear cataract in subject 111:2 from 
panel family 16, typical o f the fam ily’s phenotype
Figure 33 Panel family 17
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Figure 34 Panel family 18
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4.0 Discussion
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4.1 Overview of this thesis
This thesis illustrates the wide variety of cataract phenotypes and genotypes in 
ADCC. ADCC is a term which describes diseases which differ markedly in terms 
of visual outcome, die necessity and timing of surgical intervention and the 
underlying molecular mechanisms causing cataract. Understanding die molecular 
biology of ADCC gives us insights into die aetiology of commoner age related 
cataract This diesis adds knowledge to die field o f ADCC, both in terms of novel 
phenotypic consequences of a previously known mutation in PITX3 and in terms 
o f  discovery and functional investigation o f a novel mutation in a known cataract 
gene, CX46.
4.2 Novei phenotypic consequences of a mutation in FITX3
PITX3 encodes the transcription factor protein, PITX3. Transcription factors may 
activate or repress transcription. They play important roles in the embryological 
development of the lens and the anterior segment of the eye. Mutations in several 
transcription factor genes including PITX3,95 PAX696 FOXE3,97 EYA198 and 
MAF99,100 have been implicated in ADCC and ASMD. Most of these mutations 
are associated with ASMD and cataract in all affected individuals within the 
family although typically there is phenotypic variability. A single family with a 
mutation in MAF has been reported in which some affected members of the 
family had both ASMD and cataract, while others had isolated cataract.99’100 
Another transcription factor gene, HSF4,26 has been reported to cause isolated 
cataract in all affected individuals within a large family.
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PITXS is a member o f  the PITX  gene family and encodes a paired-like class of 
homeobox transcription factors. Both PITX2 and PTTX3 genes are involved in eye 
development and are expressed in most developing ocular tissues, including the 
cornea, lens and retina.109 Mutations in PITX2 have been reported in Rieger’s 
syndrome.110 PITXS comprises four exons and encodes a protein o f302 amino 
acid residues. Sequence analysis of this gene revealed, in exon 4, a 17bp
99duplication (657-673dup 17) that segregated with disease in all the affected 
members of both families A and B. This 17bp duplication mutation results in a 
frameshift in codon 220 and leads to the production o f an aberrant protein 
consisting of 94 additional residues. The mutation does not affect the 
homeodomain and the mechanism by which the aberrant protein leads to cataract 
and ASMD is unclear. In particular, die mechanism by which mutations in PITXS 
give rise to PPC, such a localised form of lens opacity remains unknown. A better 
understanding of die disease mechanism will be gained by future functional 
studies.
In the aphakia mouse mutant, two deletions in the promoter of die homeobox 
transcription factor PitxS lead to loss o f  its function and to arrest of eye 
development at the lens stalk stage.111 Prior to this thesis, cataract causing 
mutations in the homologous human PITXS gene had only been reported in two 
families.95 In both families, mutations caused cataracts in association with ASMD 
in all of the affected individuals. In one family, the cataract phenotype was 
cortical cataract. In die other family, die cataract phenotype was total cataract.
In large families A and B in this thesis, die same 17bp mutation in PITXS as 
previously reported results in a different phenotype, PPC, in all affected
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individuals. Only one out o f a total o f  twenty-four affected individuals in families 
A and B exhibited features of ASMD. The phenomenon of the same mutation 
causing a different phenotype in different families has been observed previously 
for the nonsense mutation, Q155X, in the CRYBB2 gene. This mutation has been 
associated with cerulean cataract,57 cerulean and sutural cataract45 and nuclear
f  o
pulverulent cataract in three unrelated families. In families A and B in this 
thesis, all the affected individuals had PPC. However, one affected individual in 
family A also exhibited features of ASMD. This variability between individuals 
carrying the same causative mutation may result from a number of factors 
including the effects of other modifier genes, intrauterine environmental factors or 
it may be due to stochastic developmental events.112
PPC has not previously been reported in association with mutations in PITXS. AD 
PPC is genetically heterogeneous. Two loci on lp3621 and 20pl2113 and mutations 
in one gene, CRYAB on 1 lq21,20 have been reported in association with this 
phenotype. Now, it has been shown that a mutation in PITX3, on 10q25, can also 
give rise to isolated PPC.22 This adds to the evidence behind our current 
understanding of the relationship between genotype and phenotype in ADCC. A 
particular cataract phenotype does not have a unique genotype, as is well 
illustrated for PPC. The multiplicity of genes causing the same or similar 
phenotype contributes to the genetic heterogeneity of ADCC. Families A and B 
illustrate a further feature of the genotype-phenotype relationship. This second 
phenomenon has been described as clinical heterogeneity indicating that 
mutations in the same gene may give rise to completely different cataract 
phenotypes. For example, mutations in CRYGD have been reported in association
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with cerulean (P23T),63 aculeiform (R58H),60 nuclear (W156X)62 and lamellar 
(P23T)62 cataract. In the case o f the P23T mutation, even with an identical 
mutation, the cataract phenotype varies between families. Environmental, or more 
likely other genetic modifiers, may play a role in determining die eventual 
phenotype in a particular family. Such modifier gene influences have been 
identified in a recessive murine cataract and it is likely that similar gene-gene 
interactions will be identified in human cataract.114 Clinical heterogeneity is also 
observed for PITXS. The same 17bp duplication mutation that was previously 
reported to cause cortical cataracts and ASMD in all of the affected individuals,95 
causes PPC with or without ASMD in all affected individuals in families A and B.
Two further families, one of English Caucasian and the other of Chinese origin, 
which display the same phenotypic consequences of this mutation in PITX3 have 
been reported by our group. In total, five genetically distinct large families with 
mutations in PITXS in association with AD PPC were reported by our group.22 
One family, o f  Hispanic origin, had a novel deletion mutation. The other four 
families had the same 17bp duplication mutation. In family B and the Chinese 
family, the phenotype is isolated PPC. In family A and die other English 
Caucasian family, one o f ten affected individuals and four of eleven affected 
individuals respectively also had ASMD.24 In this latter family, die anterior 
segment developmental abnormalities varied from peripheral sclerocomea to 
complex disorders with changes similar to Peter’s anomaly (central comeal 
opacity with iridocorneal adhesions). So, even amongst individuals within a 
family who had ASMD, the exact nature of the ASMD varied considerably.
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4.3 Novel mutation in connexin 46 gene causing ADCC
Different strategies can be used for mapping a disease depending on the clinical 
information available. If detailed phenotypic information is unavailable, whole 
genome scan or exclusion of known loci can be used to map ADCC. These 
approaches are indicated when there are no phenotypic clues as to which known 
gene or locus is involved. If the phenotype of ADCC is known, a different 
approach may be used. Known genes or loci associated with the specific 
phenotype of cataract are excluded first. Once these have been excluded, other 
known cataract genes and loci are excluded. If cataract does not map to a known 
locus, whole genome scan is required.
Whole genome scan and exclusion of known cataract loci approaches were 
initially used for mapping ADCC in the Honduran family. Once the phenotype in 
the Honduran family was known, the genes known to cause AD zonular 
pulverulent were excluded. This lead to markers around the CX46 gene being 
genotyped. A relatively high two-point LOD score of 2.53 was found using 
D13S175, a marker close to CX46. This and other adjacent markers were 
relatively uninformative in the family. However, zonular pulverulent cataract 
segregated perfectly for this marker and so the CX46 gene was sequenced. 
Sequencing revealed a novel mutation which segregated with cataract throughout 
the family. The effect of the mutation on trafficking and function of expressed 
connexin 46 protein (Cx46) was investigated.
Connexins are ubiquitous gap junction proteins which allow small informational 
molecules to be directly transmitted between cells.67 The lens expresses three 
distinct connexins.69 Cx43 is expressed mainly in lens epithelial cells, while Cx46
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and Cx50 are expressed in lens fibre cells.71'73 All but one of the eleven mutations 
in CX46 and CX50 genes that have been reported in ADCC are associated with 
AD pulverulent cataract, the phenotype in family C. This is the first time a CX46 
mutation has been reported in a family of Hispanic Central American origin. It 
widens the ethnic diversity of families with CX46 mutations causing ADCC. 
Previous mutations have been reported in five families of Caucasian and two 
families of Chinese ancestry. Screening CX46 in another large family with AD 
zonular pulverulent cataract, family D, did not demonstrate a mutation, 
highlighting the genetic heterogeneity that exists for zonular pulverulent cataract 
even when connexin mutations almost always cause pulverulent cataracts.
The CX46 gene encodes a 435 amino acid protein which has four transmembrane 
domains and two extracellular loops with cytoplasmic N and C termini. The 
mutation in the Honduran family changes the seventh nucleotide base in CX46 
from a G to a T. This results in the amino acid encoded by the third codon of 
CX46 being changed from a negatively-charged amino acid aspartate (D) to an 
uncharged amino acid tyrosine (Y). This D3 Y mutation is the first mutation 
within the N-terminal cytoplasmic tail region of CX46 to be associated with 
congenital cataract. Substitutions in the amino acid residues of the N terminus 
may interfere with the conformation and flexibility of the amino terminus and also 
with voltage gating.115’116 The D3 residue of CX46 is phylogenetically conserved 
from zebrafish to man, indicating that the aspartate is likely to be functionally 
important and that the mutation may therefore have a detrimental physiological 
effect.
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The effect of the novel mutation, D3 Y, on Cx46 trafficking was investigated.
Both by immunohistochemistry and by fluorescent fusion protein localisation, it 
was shown that the mutant Cx46 traffics to the membrane identically to wild type 
Cx46 in human HeLa cells. This strongly suggests that abnormal trafficking of 
mutant protein is not the mechanism by which it malfunctions in human lens fibre 
cells, so causing cataract. The mutation is therefore likely to affect intercellular 
communication through the Cx46 channel.
Dye transfer experiments were performed to test this hypothesis. Lucifer yellow 
dye transfer was observed between adjacent human HeLa cells transfected with a 
CX26-GFP positive control plasmid construct but was not observed in cells 
transfected with either CX46-GFP or D3Y-GFP. This was an unexpected result. It 
was thought that lucifer yellow or the smaller molecule neurobiotin would transfer 
between cells transfected with the wild type CX46-GFP construct but not with the 
D3Y-GFP construct. This would have confirmed the hypothesis that the D3Y 
mutation affects the function but not the trafficking of Cx46 in human HeLa cells. 
There are no published reports of lucifer yellow or neurobiotin transfer between 
adjacent human HeLa cells transfected with CX46-GFP. However, lucifer yellow 
dye transfer and neurobiotin transfer have previously been demonstrated using 
human HeLa cells transfected with CX26-GFP and CX30-GFP respectively.77 In 
this thesis, lucifer yellow dye transfer was demonstrated for CX26-GFP but 
neither lucifer yellow nor neurobiotin transferred between cells transfected with 
CX46-GFP or D3Y-GFP in separate experiments. There are a number of possible 
explanations for this result.
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Firstly, it is possible that neither lucifer yellow nor neurobiotin but that an 
alternative dye passes through open Cx46 gap junctions. Dye transfer has been 
demonstrated in Cx46 expressing cells using Alexa350, a coumarin derivative dye 
(Dr Reiner Eckert, personal communication). Certainly, published data for other 
connexins suggests that it is not possible to predict which molecules will pass 
through gap junctions composed of a particular connexin.77’78’83’117 A second 
possible explanation for the unexpected results is that the Cx46-GFP protein does 
not allow the normal functioning of Cx46 gap junctions to take place. The obvious 
difference between the Cx46 protein expressed in these cells and endogenous 
Cx46 is the presence of the GFP component of the protein, which allowed 
transfected cells to be identified. However, GFP tagging has been successfully 
used previously for other connexins, like Cx26 and Cx30, without affecting 
function. It is still possible though that Cx46 specifically may be 
functionally affected by GFP tagging.
Due to time constraints, it was not possible to repeat the dye transfer experiments 
using an alternative dye such as Alexa350 which could have demonstrated normal 
wild type function but abnormal mutant Cx46 protein function. Other further and 
future work is summarised in Appendix 6.8.
4.4 Final Conclusions
The complex role of transcription factors in anterior segment development has 
been highlighted by finding novel phenotypic consequences of a known mutation 
in PITX3. It is highly likely that the effects of the PITX3 mutation depend on the 
genetic background of the family and, in particular, on the effects of other
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modifier genes in affected individuals within the family. This adds to the evidence 
for clinical heterogeneity in ADCC. The fact that PITX3 is a further locus for PPC 
adds to the evidence for genetic heterogeneity in ADCC.
Finding a novel mutation in CX46 in a completely different ethnic population to 
those previously reported but with an almost identical phenotype to all the other 
known mutations suggests that, in some instances, genotype can play the major 
role in determining phenotype. Through the investigation of the functional effects 
of cataract-causing mutations, as we have begun for the D3 Y mutation in CX46, 
further insights will be gained into the fundamental biological events which 
underlie congenital cataracts. The information we gain from such functional 
studies should lead to a better understanding of the causes and potential therapies 
for age related cataract, which remains the commonest cause of blindness in the 
world.
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6.1 Genotyping
Figure 38 An example of a genotyper tracing
An individual with 2/2 genotype for marker D13S217 is shown
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6.2 Vector diagrams
Figure 39 pTARG ET vector circle map and sequence reference points
Figure 40 pG EM -T Easy vector circle map and sequence reference points
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Figure 41 pEGFP-Nl vector information
pEGFP-N1 Vector Information
GenBank Accession #U55762
ApaU
(4362) - x
Sna BI
(341)
MCS
(591-671)
EcoOm  I
(3856)
HSVTK
PT3027-5 
Catalog #6085-1
Bs/G 1(1389)
/Vof I (1402) 
A7»a I* (1412)
Afl II (1640) 
Dra 111(1874)
581 101 011 631 831 H I 651 Ml O l £G fp
G CTA 6CG CTA CCG GAC TCA GAT CTC GAG CTC AAG CTT C6AATTCTG CAG TCG ACG GTA CCG CGG GCC CGG GAT CCA CCG GTC GCC ACCATGGTC 
AM* I fc*47lll Bgl II Xho I \  tfmd III fcofll Pst I Sal I Kpn I \  Apa I BamH\ Age I
S f* ] , ,  Accl A s p m t  \  B s p \X  I Xma I
& / a i l  P S ic  II Sma I
6.3 Family A linkage studies
Table 11 Family A two-point LOD scores
M arker Location/MB 0=0 0.01 0.05 0.1 0.2 Zmax Omax
D10S1686 85.5 -oo -0.44 0.74 1.07 1.08 1.13 0.15
D10S564 92.6 3.61 3.55 3.30 2.98 2.28 3.61 0
D10S192 102.4 3.61 3.55 3.30 2.98 2.28 3.61 0
PITX3 103.9
D10S597 111.2 3.61 3.55 3.30 2.98 2.28 3.61 0
D10S1693 119.4 -00 -0.81 -0.17 0.05 0.21 0.21 0.20
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6.4 Family A PITX3 mutation
Figure 42 Direct sequencing electropherogram s showing PITX3 mutation
From an affected individual (above) and from an unaffected individual (below). The arrow  
marks where the mutation starts.
PITX3 657 17bp dup
PITX3 normal
C A E t G  C C I  E G  S C G j E G  3  C C C C C C C 5  6 6  C I G  
C A E G C t  C I  5 G Ff C C E t  C [ C t  [  [ C t  C t  C [  I C
6.5 Family C linkage studies
Table 12 Family C two-point LOD scores
The distance shown is the genetic distance from p-tel
Marker Distance/cM 0=0 0.10 0.20 0.30 0.40 Zmax Omax
D1S1316 0 1.03 0.75 0.48 0.23 0.06 1.03 0
CX46
D13S175 6.03 2.53 2.31 1.84 1.25 0.62 2.53 0
D13S1275 6.99 -oo 2.73 2.54 1.86 0.94 2.76 0.12
D13S292 7.09 1.42 1.51 1.17 0.73 0.28 1.58 0.05
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6.6 Family C CX46 mutation
Figure 43 Direct sequencing electropherogram s showing CX46 mutation 
Sequences from an affected individual (above) and an unaffected individual (below)
A T G G G C T A C T G  G A
A T G G G C G A C T G  G A
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6.7 Highly conserved third residue in connexins
Figure 44 Cross species alignment of connexin 46 and other connexins
Alignment of residues 1-60 of human Cx46 with mouse, rat and zebra fish {Danio rerio) 
orthologues is shown, together with human Cx43 and Cx50. D3 is boxed.
HumanCX46 
MouseCX46 
RatCX4 6 
DanioCX46 
HumanCX43 
HumanCX50
MG I 
MG [ 
MGI 
M G I 1 
M GI 
M GI
'WSFLGRLLENAQEHSTVIGKVWLTVLFIFRILVLGAAAEDVWGDEQSDFTCNTQQPG
•WSFLGRLLENAQEHSTVIGKVWLTVLFIFRILVLGAAAEEVWGDEQSDFTCNTQQPG
'WSFLGRLLENAQEHSTVIGKVWLTVLFIFRILVLGAAAEEVWGDEQSDFTCNTQQPG
FSSLGKLLESAQEHSTWGKVWLTVLFIFRILVLSAAAEKVWGDEQSGFTCDTKQPG
WSALGKLLDKVQAYSTAGGKVWLSVLFIFRILLLGTAVESAWGDEQSAFRCNTQQPG
WSFLGNILEEVNEHSTVIGRVWLTVLFIFRILILGTAAEFVWGDEQSDFVCNTQQPG
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6.8 Further work
As explained in section 4.3, further work might have demonstrated normal wild 
type but abnormal mutant Cx46 protein function. In addition, time constraints 
prevented co-expression of Cx46 and Cx50 constructs which would have 
simulated in vivo protein expression in the lens. Given that mutations in CX46 are 
not uncommon and that twenty-one new families were added to the cataract panel 
in this thesis, it would have been interesting to sequence affected members of each 
of these families for mutations in CX46 as was done for family D.
Inherited childhood cataracts are not uncommon. However, cataract-causing 
mutations have only been found in relatively few families. Often, the pedigrees 
illustrate autosomal dominant inheritance and yet mutations in known cataract 
genes are not found. Given our understanding of lens biology, there do not appear 
to be many more new candidate cataract genes to screen. However, it is possible 
that mutations occur in intronic regions of known cataract genes which are 
currently not sequenced. In the future, intronic cataract-causing mutations may be 
found.
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